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Abstract 
Patients with kidney disease represent a group of people who are known to have comorbidities, 
high costs of care, decreased quality of life, and invasive interventions. In rural communities of 
Western Washington State, many nephrology patients experience factors evidenced to impede 
access to quality and timely management of their disease, compounding the risk for poor 
outcomes. Telenephrology is a novel modality of service delivery with the potential to make care 
more efficient, cost-effective, flexible, and accessible. The author created this project to develop 
a telenephrology program plan and evaluation for rural settings in Western Washington, 
informed by relevant epidemiology, pathophysiology, standards of care, and evidence in the 
literature. As there are a paucity of program plans specific to this service delivery in rural 
Western Washington, development of this project aims to substantiate the need for evidence-
based implementation in this setting. The appraisal of barriers to care for this patient population 
was used to guide aspects of telenephrology program planning and evaluation to ensure 
intervention outcomes are equitable. This project provides grounds to support the adoption a new 
normal for nephrology care and utilizes the existing evidence to inform the planning and 
evaluating of telenephrology services, implementation processes, budget, and outcomes to assist 
healthcare providers and their institutions in successful integration of telenephrology in rural 






TELENEPHROLOGY  4 
Table of Contents 
 
 
Grounds for a New Normal; Integration of Telenephrology in Rural Communities ................................... 5 
Background and Significance ................................................................................................................ 6-32 
End-Stage Renal Disease ........................................................................................................................ 9 
Hemodialysis ................................................................................................................................... 10-14 
Peritoneal Dialysis ........................................................................................................................... 14-16 
Risk Factors for ESRD..................................................................................................................... 16-19 
Standards of Care for End-Stage Renal Disease............................................................................... 19-27 
Rural Community Implications ........................................................................................................ 26-32 
Theoretical Framework ......................................................................................................................... 32 
Review of literature ............................................................................................................................. 33-50 
Telenephrology ................................................................................................................................ 33-50 
Methods ............................................................................................................................................... 50-56 
Telenephrology Program Implementation ............................................................................................. 50 
Logistics ............................................................................................................................................... 51 
Timeline ................................................................................................................................................ 53 
Budget.............................................................................................................................................. 53-56 
Evaluation Plan ................................................................................................................................ 56-58 
Discussion ............................................................................................................................................ 58-60 
Conclusions ......................................................................................................................................... 60-61 
References ........................................................................................................................................... 62-82 
Appendix A 
Key Term Definitions ............................................................................................................................... 83 
Appendix B 
Table Summarizing Kidney Disease Improving Global Outcomes Guidelines for Chronic Kidney Disease 
Management ............................................................................................................................................. 85 
Appendix C 
Table Summarizing the Formats and Applications of Telenephrology ..................................................... 86 
Appendix D 
Tables 3 - 7 Summarizing the Evidence for Telenephrology Implementation by Intended Use ......... 87-103 
Appendix E 
Table 8 Depicting a Budget Plan for Telenephrology Services ........................................................ 104-105 
 
TELENEPHROLOGY  5 
Grounds for a New Normal; Integration of Telenephrology in Rural Communities 
Nephrology patients constitute a group of people who often have comorbidities, 
decreased quality of life, and an acquired need for frequent, costly, and invasive interventions 
that equate to an annual Medicare cost of $84 billion for the syndrome of chronic kidney disease 
(CKD) alone (Agarwal, 2020; Centers for Disease Control and Prevention [CDC], 2019; Colbert, 
Venegas-Vera & Lerma, 2020; Jain, Ahmad & Wallace, 2020; Koraishy & Rohatgi, 2020). 
When patients progress to renal failure, also known as end-stage renal disease (ESRD), the 
burden on patients and healthcare cost multiplies. ESRD management requires frequent laborious 
interventions that cost around $56,300 more per patient per year than CKD (CDC, 2019). At the 
onset of the COVID-19 (coronavirus disease-2019) pandemic, the United States’ healthcare 
systems became abruptly aware of populations that were especially vulnerable to the 
consequences of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection. Due 
to the intensive nature of nephrology care and immunodeficiency resulting from renal damage, 
patients with kidney disease are posed to be disproportionately impacted by COVID-19 as well 
as the ensuing policy changes (Agarwal, 2020; Colbert, Venegas-Vera & Lerma, 2020; Jain, 
Ahmad & Wallace, 2020; Koraishy & Rohatgi, 2020).  
In rural settings, this baseline risk can be compounded by factors evidenced to impede 
access to quality and timely management of disease (Agarwal, 2020; Colbert, Venegas-Vera & 
Lerma, 2020; Jain, Ahmad & Wallace, 2020; Koraishy & Rohatgi, 2020; Osman et al., 2017; 
Washington State Department of Health [WDOH], 2017). For rural communities in Western 
Washington State, data illustrate these areas characteristically have underdeveloped public 
transportation, substantial distance between patients and their specialty care facilities, and a 
relatively high prevalence of social and economic risk factors (Agarwal, 2020; clinician, personal 
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communication, May 4, 2020; Colbert, Venegas-Vera & Lerma, 2020; Jain, Ahmad & Wallace, 
2020; Koraishy & Rohatgi, 2020; Osman et al., 2017; WDOH, 2017; WDOH, 2019). 
While the necessary social distancing precautions brought on by the COVID-19 
pandemic created challenges to healthcare delivery, it simultaneously made widespread adoption 
of virtual care services possible in quick succession (Agarwal, 2020; Jain, Ahmad & Wallace, 
2020; clinician, personal communication, May 4, 2020). Telenephrology, the application of 
telehealth modalities in the field of nephrology, was widely adopted at an unprecedented rate as a 
provisional solution to mitigate risk of patient and provider SARS-CoV-2 exposure (Agarwal, 
2020; Jain, Ahmad & Wallace, 2020; White & Kribs, 2020). However, in making these services 
the new normal beyond the pandemic paradigm, there is potential to address critical healthcare 
access barriers - both geographical and socio-economic - that are characteristic of nephrology 
patients living in rural Western Washington (Agarwal, 2020; Ishani et al., 2016; Jain, Ahmad & 
Wallace, 2020; Osman et al., 2017; Rohatgi, Ross & Majoni, 2017; WDOH, 2017; WDOH, 
2019; White & Kribs, 2020). This project seeks to substantiate the need for continued use of 
telenephrology services and provide a program plan as a resource for further development and 
implementation of telenephrology in rural communities of Western Washington. 
Background and Significance 
Kidney Disease 
Globally, nationally, and regionally, kidney disease poses a significant burden on both 
patients and healthcare systems. Kidney disease is the ninth leading cause of death in the United 
States, with an estimate of 37 million Americans living with chronic kidney disease (CKD) 
(CDC, 2017; CDC, 2019; United States Renal Data System [USRDS], 2020). CKD is defined as 
a reduction in function or kidney damage that has been present for at least three months (CDC, 
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2019; Kochanek et al., 2019; Villarroel, Blackwell & Jen, 2018). Unfortunately, due to the 
insidious nature of kidney diseases, nine out of ten adults with CKD do not know they have it 
(CDC, 2019). Whether a formal diagnosis has been given or not, CKD leads to $84 billion in 
annual Medicare Costs, while progression to end stage renal disease (ESRD) costs $36 billion 
(CDC, 2019).  
Nearly 786,000 people in the U.S. are living with ESRD, with 71 percent relying on 
dialysis and 29 percent having received a kidney transplant (Alhamad, Cheng, & Vijayan, 2021; 
Norman, 2020; USRDS, 2020). For adults, ESRD is largely caused by diabetes and high blood 
pressure while ESRD in those 18 years and younger is mainly caused by polycystic kidney 
disease and glomerulonephritis (Alhamad, Cheng, & Vijayan, 2021; Norman, 2020; CDC, 2019; 
USRDS, 2020). Ultimately, the financial burden of advancing to renal failure equates to more 
costly management of disease with an annual Medicare spending of $80,000 per patient while 
CKD costs $23,700 per person (CDC, 2019). 
Nationally, kidney diseases (nephritis, nephrotic syndrome, and nephrosis) are 
responsible for 15.7 per 100,000 deaths (CDC, 2019; USRDS, 2020). Due to the consequences 
of CKD, diseases affecting other organ systems are often accelerated, resulting in untimely death 
(CDC, 2020; Norman, 2020; USRDS, 2020). Patients with CKD are at increased risk for heart 
disease, heart failure, stroke, and early all-cause death, all of which make tracking the mortality 
burden of kidney disease difficult (Alhamad, Cheng, & Vijayan, 2021; Norman, 2020; CDC, 
2020; USRDS, 2020). For instance, people with an estimated glomerular filtration rate (eGFR) of 
15 to 59 and macroalbuminuria experience cardiovascular mortality at a rate of 41 per 1,000 
patient-years, while people with a normal eGFR and no albuminuria are at a rate of 5 per 1,000 
patient-years (CDC, 2017; USRDS, 2020). 
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In Washington State, kidney disease mortality accounts for 4.8 per 100,000 of all cause 
deaths (CDC, 2020). Approximately, 15 to 20 per 100 people in the Western regions of the state 
are living with CKD while around 1,600 per million state residents are known to have ESRD 
(CDC, 2019). In conjunction, Washington’s diabetes mellitus prevalence is about one in eight 
adults with 20-40% of them not receiving recommended preventive medical services (WDOH, 
2019). This is important to note as people with diabetes are 4.6 times as likely than the general 
population to develop kidney disease (CDC, 2019; WDOH, 2019). Rural areas in the Western 
region of the state have some of the highest rates of diabetes mellitus with 10.6% to 12.5% of 
adults having been diagnosed (WDOH, 2019).  
Kidney disease imposes significant morbidity and its effect on health and quality of life 
becomes more severe as renal dysfunction advances (Alhamad, Cheng, & Vijayan, 2021; CDC, 
2019; Mandal, 2014; Norman, 2020; USRDS, 2020). As kidney disease worsens, incidence of 
health problems like anemia, fluid overload, weakened immune system, loss of appetite, sexual 
dysfunction, sleep disturbance, confusion, depression, and electrolyte imbalances increase (CDC, 
2020; USRDS, 2020). In turn, these health problems can lead to serious consequences for 
patients, communities, and health systems (CDC, 2017; Mandal, 2014; Norman, 2020; USRDS, 
2020). Across the lifespan, U.S. statistics show that worsening of kidney disease is associated 
with worsening physical disability that progressively impairs the ability to maintain activities of 
daily living, leisure and social activities, and the ability to work (CDC, 2017; USRDS, 2020). In 
addition to physical impairments, advancement of renal dysfunction is associated with lower 
levels of performance in tasks that require cognitive function, even when adjusted for age (CDC, 
2017). For older adults in the U.S., self-reported disabilities in concentrating, doing errands 
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alone, dressing and bathing, hearing, and seeing increase as kidney function decreases (CDC, 
2017).  
Consequently, patients with kidney disease frequently interact with healthcare systems, 
encounter substantial financial requirements for interventions and challenging care-plan 
decisions that require considerable medical literacy about their disease (Kiousi & Grapsa, 2015; 
Molzahn, Bruce & Sheilds, 2008; Perlman et al., 2004). Patients with CKD have been measured 
to have lower quality of life (QOL) compared to the general population as a result, while patients 
who have progressed to ESRD and require renal replacement therapy have even lower QOL 
measures and increased healthcare costs (Molzahn, Bruce & Shields, 2008; Perlman et al., 2004).  
End-Stage Renal Disease 
 While not everyone with CKD progresses to kidney failure, reaching an end-stage of 
renal function is inevitably fatal without intervention (Alhamad, Cheng, & Vijayan, 2021; 
National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2017; Norman, 
2020). When patients reach 15 percent or less of normal kidney function, buildup of bodily waste 
products and fluid poses the need to consider different management strategies (Alhamad, Cheng, 
& Vijayan, 2021; NIDDK, 2017). Traditionally, at this stage of kidney disease, hemodialysis 
(HD), peritoneal dialysis (PD), or kidney transplant become the mainstays of treatment 
(Alhamad, Cheng, & Vijayan, 2021; Berns, 2020; Bleyer, 2020; NIDDK, 2017). Depending on 
the patient’s goals of care, conservative, supportive, or palliative care may be appropriate 
management strategies as dialysis and transplant interventions are notably invasive and costly 
(Alhamad, Cheng, & Vijayan, 2021; Berns, 2020; Mandal, 2014).   
In ESRD, patients will begin to develop uremic symptoms because of accumulating waste 
products and fluid in the body (Alhamad, Cheng, & Vijayan, 2021; Bleyer, 2020; Norman, 
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2020). This results in patients experiencing; nausea, vomiting, lethargy, pruritis, impaired 
cognitive function, a metallic after-taste, edema, motor neuropathies and pericarditis (Alhamad, 
Cheng, & Vijayan, 2021; Norman, 2020). When the kidneys can no longer maintain their 
physiological function, dialysis can act as a replacement to clear uremic substances, adjust serum 
electrolytes and remove accumulation of fluid (Alhamad, Cheng, & Vijayan, 2021; NIDDK, 
2017; Norman, 2020). While the advent of renal replacement therapy has served as a viable life-
sustaining intervention, compared to the general population, dialysis users have a seven to eight 
times higher mortality rate, necessitating every effort be made to preserve kidney function 
(Alhamad, Cheng, & Vijayan, 2021; CDC, 2017; Mandal, 2014; USRDS, 2020). 
Hemodialysis 
Hemodialysis is the most common form of renal replacement therapy (RRT) in the 
United States, with over 430,000 ESRD patients relying on this treatment (Alhamad, Cheng, & 
Vijayan, 2021; Burkart, 2019; CDC, 2017; USRDS, 2020). The largest group of HD users fall 
between the ages of 45 and 64 years old as younger patients are more likely to utilize PD or 
receive a kidney transplant (Alhamad, Cheng, & Vijayan, 2021; USRDS, 2020). The population 
using HD is predominantly white (56 percent) and male (57 percent), with 37 percent of HD 
users being Black and 5 percent being Asian (Alhamad, Cheng, & Vijayan, 2021). When patients 
have reached ESRD, mortality rates increase dramatically with a 63 percent probability of death 
for non-diabetics within five years of initiating HD and 71 percent for those with diabetes 
(Alhamad, Cheng, & Vijayan, 2021).  
 To begin maintenance HD, effective dialysis access, or system for blood delivery 
between the patient and machine, must be established (Alhamad, Cheng, & Vijayan, 2021; 
NIDDK, 2017; Schmidt, 2020). Three types of HD access exist: arteriovenous fistulas (AVF), 
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arteriovenous grafts (AVG), and dialysis catheters (Alhamad, Cheng, & Vijayan, 2021; NIDDK, 
2017; Norman, 2020). AVF, the most desirable form of access, and AVG, act as conduits where 
they are cannulated by two needles; one being for collection of arterial blood flow that will be 
dialyzed through a machine and the other being for return of blood into the venous system 
(Alhamad, Cheng, & Vijayan, 2021; Allon, 2021 [1]; Schmidt, 2020). To establish AVF access, 
patients will need to go under regional anesthesia to have surgical manipulation of the patient’s 
native vasculature (Alhamad, Cheng, & Vijayan, 2021; Allon, 2021 [1]). This process involves 
interprofessional planning and a waiting period of three to four months after placement so the 
fistula can mature to withstand flow from large bore needles (Alhamad, Cheng, & Vijayan, 2021; 
Allon, 2021 [1]). This procedure is not without risk, as complications like thrombosis, infection 
and vascular steal can occur (Alhamad, Cheng, & Vijayan, 2021). While AVF is preferred due to 
having lower rates of complications and higher potential for long-term patency, it is not 
uncommon for patients to undergo trials and failure of AVF in multiple sites due to a lack of 
healthy vasculature (Alhamad, Cheng, & Vijayan, 2021; Allon, 2021 [1]). 
 If AVF access cannot be established, placement of a synthetic graft for AVG access can 
be used to bypass the need for healthy native vasculature (Alhamad, Cheng, & Vijayan, 2021; 
Allon, 2021 [2]). The advantages of AVG include a large surface area for cannulations and a 
shorter maturation time of 2 to 3 weeks which allows for earlier dialysis use in time-sensitive 
situations (Alhamad, Cheng, & Vijayan, 2021; Allon, 2021 [2]). While AVG access can act as a 
good alternative or a starting off procedure for earlier access to renal replacement therapy, the 
graft only has an average lifespan of about two years (Alhamad, Cheng, & Vijayan, 2021; Allon, 
2021 [2]).  
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 As a last resort for HD access, a catheter can be placed, typically in the right internal 
jugular vein and looped to exit just below the ipsilateral clavicle (Alhamad, Cheng, & Vijayan, 
2021). This form of HD access is least desirable as there is significant risk for infection, catheter 
dysfunction, difficulties with recirculation and variable success sustaining adequate flow 
(Alhamad, Cheng, & Vijayan, 2021).  
 Using patient preference, resources, and capabilities as a guide, a modality of HD is 
selected. This involves careful consideration of patient distance from the facility, independence, 
schedule, and capacity to sustain cumulative dialysis dosing (Alhamad, Cheng, & Vijayan, 2021; 
Berns, 2020; Norman, 2020; Qunibi, 2020). Intermittent In-center HD is the most common 
modality which involves the patient receiving dialysis at a facility two to three times per week 
with each session being about 3 to 4 hours in duration (Alhamad, Cheng, & Vijayan, 2021; 
Berns, 2020). This modality is especially popular among new HD users as dialysis facilities have 
trained staff to set up and supervise each treatment in a controlled environment (Alhamad, 
Cheng, & Vijayan, 2021). Short Daily HD is an alternative modality where patients have shorter 
durations of dialysis but need to receive more frequent treatments, typically six days per week, to 
achieve an adequate cumulative dialysis dose (Alhamad, Cheng, & Vijayan, 2021; Qunibi, 
2020). This modality is typically performed at home, but some dialysis facilities can 
accommodate to provide this service (Alhamad, Cheng, & Vijayan, 2021). By dividing 
treatments into more frequent and shorter intervals, patients can often avoid intradialytic 
complications like hypotension and cramping (Alhamad, Cheng, & Vijayan, 2021; Qunibi, 
2020). However, the drawbacks of sustaining daily treatments and increased risk for vascular 
complications are worth consideration (Alhamad, Cheng, & Vijayan, 2021; Allon, 2021 [1]; 
Allon, 2021 [2]; Burkart, 2019). The last modality, Nocturnal HD, involves a larger cumulative 
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dialysis dose where patient receive an average of 6 to 8 hours of treatment nightly about six 
times per week (Alhamad, Cheng, & Vijayan, 2021; Qunibi, 2020). This modality can also be 
performed at home, allowing patients more freedom during the day, although it, like Short Daily 
HD, has the concern for burden of daily treatments and increased risk for vascular complications 
(Alhamad, Cheng, & Vijayan, 2021; Mailloux & Blagg, 2016). 
 Only three percent of RRT is achieved through home hemodialysis (HHD) in the U.S. 
(Alhamad, Cheng, & Vijayan, 2021; CDC, 2017; Mailloux & Blagg, 2016; USRDS, 2020).  The 
small proportion of HHD users is largely due to the Social Security Act of 1972 that allowed for 
a rapid expansion of outpatient dialysis centers (Alhamad, Cheng, & Vijayan, 2021; Mailloux & 
Blagg, 2016). Along with improved patient satisfaction and QOL, the capacity to do more 
frequent sessions of dialysis and eliminate two-day interdialytic gaps provides measurable 
benefits in patient outcomes (Alhamad, Cheng, & Vijayan, 2021; Burkart, 2019; Mailloux & 
Blagg, 2016). HHD is a form of RRT that offers potential to achieve patient-centered care 
(Alhamad, Cheng, & Vijayan, 2021; Burkart, 2019; Mailloux & Blagg, 2016). However, there 
are stipulations worthy of consideration to ensure success of this therapy. With all home-based 
RRTs, patients and their caregivers need to be highly motivated and adequately prepared for the 
responsibility of independently managing their interventions (Alhamad, Cheng, & Vijayan, 
2021; Berns, 2020; Mailloux & Blagg, 2016; NIDDK, 2017). The Food and Drug Administration 
(FDA) require that patients (and their caregivers when indicated) complete roughly twenty HHD 
training sessions prior to initiation (Alhamad, Cheng, & Vijayan, 2021). Additionally, home 
water supply for safe dialyzing is critical and requires water testing prior to use of HHD 
machines (Alhamad, Cheng, & Vijayan, 2021). Ensuring patients and their support systems are 
informed on the cost of dialysis prescriptions and the need to maintain sterile technique is 
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essential to HHD safety and success (Alhamad, Cheng, & Vijayan, 2021; Mailloux & Blagg, 
2016; Schmidt, 2020). While HHD offers the convenience of completing RRT without frequent 
visits to dialysis centers, clinical monitoring of the patient’s dialysis access site, blood pressure, 
symptoms, and dialysate saturation are still necessary aspects of care (Alhamad, Cheng, & 
Vijayan, 2021; Berns, 2020; Mailloux & Blagg, 2016; Schmidt, 2020). 
Peritoneal Dialysis 
PD is a form of RRT that utilizes the patient’s peritoneal membrane and its associated 
capillaries as a semipermeable membrane to sustain an equilibrium of solutes between the blood 
and the peritoneal space where dialysis solution is infused (Alhamad, Cheng, & Vijayan, 2021). 
PD is a sustainable and patient-centered form of RRT that is more affordable, requires fewer 
hospitalizations, fewer vascular complications and has greater patient satisfaction than in-center 
HD (Alhamad, Cheng, & Vijayan, 2021; Burkart, 2019; Pirkle, 2019). However, less than 15 
percent of dialysis patients in the U.S. are enrolled in this form of RRT (Alhamad, Cheng, & 
Vijayan, 2021; Berns, 2020; Pirkle, 2019; USRDS, 2020). Patient selection for PD involves 
careful assessment for relative and absolute contraindications. Generally, patients who are good 
candidates for PD are highly motivated, independent, and capable of performing regular home-
based treatments, seven days a week (Alhamad, Cheng, & Vijayan, 2021; Pirkle, 2019). While 
PD allows for flexibility in schedules and is more conducive to work or travel, certain 
physiologic factors may bar patients from this option. Factors like recent or frequent intra-
abdominal surgeries, uncorrectable abdominal defects, frequent intra-abdominal infections, 
adhesions, and abdominal wall cellulitis are contraindications to PD (Alhamad, Cheng, & 
Vijayan, 2021; Burkart, 2019; Pirkle, 2019).  
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To initiate PD, a silastic intraperitoneal catheter is placed either laparoscopically or 
percutaneously under ultrasound guidance (Alhamad, Cheng, & Vijayan, 2021). These catheters 
can be used immediately after placement, although a waiting period of ten to 28 days is preferred 
to allow for healing (Alhamad, Cheng, & Vijayan, 2021; Pirkle, 2019). Like HD, PD has 
modality options to choose from depending on the patient’s peritoneal membrane type which is 
determined by a peritoneal equilibration test (Alhamad, Cheng, & Vijayan, 2021). High transport 
membranes are suited for short, repeated dwells while low transport membranes are better suited 
for long, evenly spaced dwells of continuous ambulatory peritoneal dialysis (CAPD) (Alhamad, 
Cheng, & Vijayan, 2021; Pirkle, 2019). CAPD is a manual type of exchange where dwell times 
range from six to eight hours (Alhamad, Cheng, & Vijayan, 2021). Patients using PD dialysis are 
typically taught CAPD when they initiate treatment as the knowledge and ability to perform this 
manual type of dialysis becomes critical should there be a power outage or machine malfunction 
(Alhamad, Cheng, & Vijayan, 2021; Pirkle, 2019). Depending on resources, patients can then opt 
for automated PD exchanges or continuous cycling peritoneal dialysis (CCPD). Although the 
nomenclature implies continuous exchanges, unlike CAPD, the continuous cycling refers to 
around the clock solute transfer following roughly three short cycles of dialysis overnight 
(Alhamad, Cheng, & Vijayan, 2021; Pirkle, 2019). Depending on the patient’s membrane type, 
an extra daytime exchange of manual CAPD may be necessary (Alhamad, Cheng, & Vijayan, 
2021; Pirkle, 2019).  
While PD functions as a viable form of RRT, it is not without complications. 
Characteristically, patients on PD are at increased risk for peritonitis, catheter site infections, 
outflow failure (from constipation, catheter migration, catheter kinking, adhesion formation, 
omental wrapping or fibrin plugging), back pain, hernias, fluid leaking, sclerosing encapsulating 
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peritonitis, hyperglycemia, hyperlipidemia, malnutrition, and hypokalemia (Alhamad, Cheng, & 
Vijayan, 2021; Pirkle, 2019). The inability to resolve these complications, along with failure to 
achieve adequate therapy targets and inadequate fluid removal, may necessitate a permanent 
switch to HD (Alhamad, Cheng, & Vijayan, 2021).  
Risk Factors for ESRD 
 
The renal system both influences and is influenced by a myriad of risk factors (CDC, 
2019; Norman, 2020; Kiousi & Grapsa, 2015). The kidney is intricately bound to the 
homeostasis of nearly every other organ system creating a loop of cause and effect that is heavily 
influenced by social and economic factors (Alhamad, Cheng, & Vijayan, 2021; CDC, 2019; 
Kiousi & Grapsa, 2015; Norman, 2020; USRDS, 2020). Kidney diseases have been shown to 
affect males, those who are 65 years and older, obese, of lower socioeconomic status, and non-
white persons at much higher rates and severity than their counterparts (Alhamad, Cheng, & 
Vijayan, 2021; CDC, 2017; CDC, 2019; USRDS, 2020).  
While CKD is diagnosed with objective and mathematical measures, it is an ongoing, 
cyclical process of renal injury and compensatory hyperfiltration (Norman, 2020). Healthy 
nephrons (functional unit of the kidney) compensate net filtration for damaged nephrons and in 
turn sustain destruction from the offset (Norman, 2020). If left untreated, this process 
progressively causes destruction to the kidneys and other organs (Alhamad, Cheng, & Vijayan, 
2021; Kiousi & Grapsa, 2015; Norman, 2020). 
The pathophysiology of CKD largely depends on the underlying cause (Alhamad, Cheng, 
& Vijayan, 2021; Norman, 2020). Development of CKD and progression to ESRD is most 
commonly caused and exacerbated by diabetes and hypertension (Alhamad, Cheng, & Vijayan, 
2021; CDC, 2017; CDC, 2019; Kiousi & Grapsa, 2015). Both Type 1 and Type 2 diabetes cause 
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a distinct form of CKD referred to as diabetic nephropathy (DN), often manifesting as 
albuminuria and hyperfiltration in earlier stages (Alhamad, Cheng, & Vijayan, 2021; Kiousi & 
Grapsa, 2015). While the exact pathophysiologic processes of DN are unknown, it is postulated 
that hyperglycemia inflicts end-organ damage to the kidneys, causing glomerular damage and 
thickening of the basement membrane, afferent & efferent arterioles (Alhamad, Cheng, & 
Vijayan, 2021; Norman, 2020). Hypertensive nephropathy is known to induce kidney injury 
through a variety of mechanisms. The distinctive overactivity of the sympathetic system in 
hypertension leads to decreased outflow from the glomerulus of the nephron through constriction 
of the efferent arteriole (Alhamad, Cheng, & Vijayan, 2021; Norman, 2020). This process leads 
to increased oncotic pressure in the nephron resulting in injury (Norman, 2020). In a cyclical 
fashion, arterial stiffness and subsequent impaired salt and water excretion increase blood 
pressure and further kidney injury (Norman, 2020). Other causes of kidney injury and risk for 
subsequent CKD include immune complex deposition, genetic etiologies, and interstitial damage 
from nephrotoxic agents (Alhamad, Cheng, & Vijayan, 2021; Norman, 2020).  
Diabetes accounts for forty-four percent of ESRD cases while hypertension accounts for 
twenty-nine percent (Alhamad, Cheng, & Vijayan, 2021; CDC, 2017; CDC, 2019; USRDS, 
2020). The development of DN before or after progression to ESRD imparts significant increases 
in morbidity and mortality, causing a 50 percent higher risk for mortality in those initiating 
dialysis (Alhamad, Cheng, & Vijayan, 2021). Moreover, diabetes and hypertension frequently 
occur together, causing an additive deleterious effect on renal health (Alhamad, Cheng, & 
Vijayan, 2021; Norman, 2020). Other causes of ESRD include glomerulonephritis, interstitial 
nephritis, autosomal dominant polycystic kidney disease, and collagen vascular disease 
(Alhamad, Cheng, & Vijayan, 2021; Norman, 2020). For all racial groups, cases of diabetes 
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caused ESRD increase with age (Norman, 2020). However, there are dramatic racial disparities 
of ESRD prevalence, with non-white patients being four times more likely to require dialysis 
(Norman, 2020; USRDS, 2020). When compared to their white counterparts, prevalence is 9.5 
times greater in Native Hawaiians/Pacific Islanders, 3.7 times greater in African Americans, 1.5 
times greater in American Indians/Alaska Natives, and 1.3 times greater in Asian Americans 
(Alhamad, Cheng, & Vijayan, 2021; CDC, 2017; Norman, 2020, USRDS, 2020).  While genetic 
factors, like the APOL1 gene in African Americans, are known to increase risk for kidney 
disease, socioeconomic factors play a major role in contributing to racial disparity (Alhamad, 
Cheng, & Vijayan, 2021; CDC, 2017; CDC, 2019; Norman, 2020).  
Geographical distance from healthcare facilities and specialty nephrology care is another 
factor that has been shown to impede access and be associated with worse outcomes (Batsis et 
al., 2019; Osman et al., 2017). Patients with kidney disease who live substantial distances from a 
nephrology practice are more likely to have missed appointments and receive less treatment 
compared to those that live closer (Koraishy & Rohatgi, 2020). Consequently, these 
geographically isolated patients are also more likely to be hospitalized and experience mortality 
at higher rates (Koraishy & Rohatgi, 2020). Furthermore, for those initiating dialysis, adjusted 
death rates have been found to be significantly higher in those living further away from their 
nephrology clinic (Koraishy & Rohatgi, 2020; Osman et al., 2017). 
 Given the success of interventions proven to slow the progression of kidney disease and 
prevent its many complications, early identification of disease and proactive management is 
paramount to achieve better health outcomes (Alhamad, Cheng, & Vijayan, 2021; Kiousi & 
Grapsa, 2015; Shlipak et al., 2021). However, in these high-risk groups, social factors often 
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make accessing adequate care challenging, laying a framework for disparities in prevalence and 
severity (Kiousi & Grapsa, 2015; Norman, 2020; Shlipak et al., 2021).  
Standards of Care for End-Stage Renal Disease 
 
The burden of kidney disease on both patients and healthcare systems is largely 
preventable. Through adequate preventive healthcare, appropriate management of comorbidities, 
early identification of disease and proactive care, the impact of renal disease could be 
ameliorated (Alhamad, Cheng, & Vijayan, 2021; CDC, 2019; Hirano et al., 2019; Kiousi & 
Grapsa, 2015; Mandal, 2014; Shlipak et al., 2021). While there is a significant body of evidence 
available to guide practice in the care of nephrology patients, renal syndromes are exceedingly 
complex and seldom have a sole effect on the kidney. This, along with trait risk factors, often 
create a necessity for interprofessional involvement and acknowledgement of socioeconomic 
impacts to individualize management and achieve standard of care (Hirano et al., 2019; Mandal, 
2014; Shlipak et al., 2021; Zuniga et al., 2020).  
Chronic kidney disease is progressive in nature, where damage to kidney tissue causes 
permanent scaring and loss of function over time (CDC, 2019; NIDDK, 2017). Interventions 
prior to and following diagnosis of CKD largely dictate the rate and severity of progression to 
ESRD, making access to evidence-based care vital (Hirano et al., 2019; Levin et al., 2013; 
Mandal, 2014; Shlipak et al., 2021). Early detection of CKD and referral to specialized 
nephrology care have been shown to improve outcomes and reduce costs of care, making 
screening a pivotal aspect of renal health (Hirano et al., 2019; Levin et al., 2013; Shlipak et al., 
2021).  
KDIGO (Kidney Disease Improving Global Outcomes) guidelines offer an evidence-
based algorithm that urges health care professionals to screen high-risk groups regularly, using 
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urinary albumin-creatinine ratio (ACR) and eGFR (estimated glomerular filtration rate) in a 
distribution that is tailored to the community risk and demographics (Levin et al., 2013; Shlipak 
et al., 2021). Using eGFR and ACR values, patients are assigned to a stage of CKD, allowing for 
risk stratification and guidance of therapy (Levin et al., 2013). KDIGO guidelines also 
recommend evaluation for other CKD criteria including urine sediment abnormalities, electrolyte 
imbalance, histological findings and structural abnormalities as indicated (Levin et al., 2013). 
Through patient findings and history, a cause for CKD should be established to best guide 
therapy (Hirano et al., 2019; Levin et al., 2013). Following diagnosis, the frequency of 
measuring serum creatinine (sCr) to calculate eGFR will determine the confidence in assessing 
the rate of progression (Levin et al., 2013). See Figure 1 for KDIGO guidelines on staging and 
frequency of monitoring. 
Figure 1 
Kidney Disease Improving Global Outcomes Guidelines for Chronic Kidney Disease Staging & 
Frequency of Monitoring  
 
Note. GFR= glomerular filtration rate. (Levin et al., 2013). 
 
TELENEPHROLOGY  21 
When a patient’s eGFR reaches 30 mL/min or lower (and in many cases 60 mL/min or 
lower in patients with high risk for disease progression) they should be referred to a nephrologist 
(Alhamad, Cheng, & Vijayan, 2021; Levin et al., 2013; Stengel et al., 2021). Factors associated 
with progression of renal disease include etiology, eGFR and albuminuria at diagnosis, age, sex, 
race/ethnicity, elevated blood pressure, smoking status, obesity, hyperglycemia, dyslipidemia, 
history of cardiovascular disease, and ongoing exposure to nephrotoxic agents (Alhamad, Cheng, 
& Vijayan, 2021; Levin et al., 2013; Stengel et al., 2021). Patients with CKD should be closely 
monitored and managed to achieve blood pressure control, RAS (renin-angiotensin system) 
inhibition, lowered salt and protein intake, glycemic control, diet optimization and lifestyle 
modification. (Alhamad, Cheng, & Vijayan, 2021; Hirano et al., 2019; Levin et al., 2013; 
Stengel et al., 2021). See Table 1 within Appendix B for specific management strategies and 
medications. While specialized nephrology care practices often have more capacity and 
preparation to coordinate these aspects of care, PCPs are responsible for initiating these 
interventions early in disease course to provide potential for better outcomes (Alhamad, Cheng, 
& Vijayan, 2021; Hirano et al., 2019; Levin et al., 2013).  
Patients with CKD are at risk for various complications that can both affect and be 
affected by progression of disease (Alhamad, Cheng, & Vijayan, 2021; Kiousi & Grapsa, 2015; 
Mandal, 2014). These complications include hypertension, volume overload, hyperkalemia, 
metabolic acidosis, hyperuricemia, hyperlipidemia, anemia, cardiovascular events, acute kidney 
injury, and renal osteodystrophy (CKD Mineral and Bone Disorder [CKD-MBD]) (Alhamad, 
Cheng, & Vijayan, 2021). Detecting and treating these outcomes involves regular screening, 
frequent encounters with healthcare providers, procedures, and pharmacologic interventions 
(Hirano et al., 2019; Mandal, 2014).  
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Given the risk for complications, care of the patient with progressive CKD involves 
efficiently coordinated interprofessional management (Alhamad, Cheng, & Vijayan, 2021; 
Hirano et al., 2019; Levin et al., 2013; Stengel et al., 2021). In addition to nephrology care, 
multidisciplinary teams often provide services including preventive measures (i.e., 
immunizations, smoking cessation), dietary counseling, health education, RRT counseling, 
transplant planning, vascular access surgery, psychological and social care (Hirano et al., 2019; 
Kiousi & Grapsa, 2015; Levin et al., 2013; Mandal, 2014). As the severity of CKD increases, 
patients need to attend more frequent follow up visits to maintain standard of care (Hirano et al., 
2019; Kiousi & Grapsa, 2015; Mandal, 2014). In late stages of disease, it is not uncommon for 
patients with advanced CKD to have a healthcare encounter every three to four weeks, not 
including dialysis treatments (Hirano et al., 2019; Mandal, 2014). While frequent visits offer 
benefit in continuity of care, increasing numbers of encounters simultaneously become 
burdensome to patients and their families (Hirano et al., 2019; Kiousi & Grapsa, 2015; Mandal, 
2014).  
Registered dietitian and certified diabetes educator services. 
Dietary and diabetes self-care counseling from trained and certified professionals have 
become a routine aspect of the evidence-based care for patients with renal disease (Alhamad, 
Cheng, & Vijayan, 2021). These ancillary services have largely become a mainstay in CKD 
management due to the effect diet and patient behaviors have on clinical outcomes (Alhamad, 
Cheng, & Vijayan, 2021; Beerendrakumar, Ramamoorthy & Haridasan, 2018; Kalantar-Zadeh, 
2013; Paes-Barreto et al., 2013). Prior to initiation of RRT, the level of glycemic control and 
adherence to protein, fat, phosphorus, calcium, potassium, and salt restriction have major 
implications on rates of progression, morbidity, and mortality (Alhamad, Cheng, & Vijayan, 
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2021; Beerendrakumar, Ramamoorthy & Haridasan, 2018; Chang et al., 2020; Duncan et al., 
2011; Kalantar-Zadeh, 2013; Paes-Barreto et al., 2013; Shurraw et al., 2011). Once patients 
initiate RRT, glycemic control continues to have major implications for morbidity and mortality 
(Alhamad, Cheng, & Vijayan, 2021; Chang et al., 2020; Shurraw et al., 2011). However, 
initiation of dialysis involves adaptations to the pre-RRT diet that are equally important to 
patient outcomes (Beerendrakumar, Ramamoorthy & Haridasan, 2018; Kalantar-Zadeh, 2013; 
Paes-Barreto et al., 2013). Even with the use of phosphorus binders, dietary intake of phosphorus 
remains one of the strongest predictors for morbidity and mortality in patients receiving RRT 
(Kalantar-Zadeh, 2013). 
Providing Registered Dietitian (RD) counseling to support patient diet optimization has 
been shown to be associated with better adherence and improved clinical outcomes 
(Beerendrakumar, Ramamoorthy & Haridasan, 2018; Kalantar-Zadeh, 2013; Paes-Barreto et al., 
2013). Similar to frequent nephrologist visits, data suggest a dose-response relationship in 
frequency of RD encounters where patients have better adherence and clinical outcomes the 
more often they receive RD counseling (Beerendrakumar, Ramamoorthy & Haridasan, 2018; 
Kalantar-Zadeh, 2013). Furthermore, RD counseling that incorporates patients’ support systems 
and family into education and planning provide even better outcomes in diet adherence and 
clinical outcomes (Beerendrakumar, Ramamoorthy & Haridasan, 2018). The disparities seen in 
CKD prevalence and severity are mirrored in the access to and success of RD counseling. 
Patients with CKD who are unemployed, smoke tobacco, have lower levels of education, speak 
English as a second language, and experience food insecurity have been shown to have less 
encounters with RDs and impaired adoption of dietary modifications due to socioeconomic 
barriers (Beerendrakumar, Ramamoorthy & Haridasan, 2018).  
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Due to the detrimental effects of poorly controlled diabetes in patients with CKD, 
optimizing glycemic control is paramount (Alhamad, Cheng, & Vijayan, 2021; Burke, Sherr & 
Lipman, 2014; Duncan et al., 2011; Shurraw et al., 2011). Patients who exhibit metabolic 
syndrome and diabetes are frequently prescribed lifestyle and dietary modifications in 
conjunction with various pharmacologic interventions to maintain healthy blood sugar levels and 
improve clinical outcomes (Alhamad, Cheng, & Vijayan, 2021; Burke, Sherr & Lipman, 2014; 
Duncan et al., 2011; Shurraw et al., 2011). However, patient capacity to adopt these 
interventions outside of the exam room will largely dictate their success (Burke, Sherr & 
Lipman, 2014; Duncan et al., 2011).  
Over the years, the literature has increasingly acknowledged the notion that the provision 
of information alone does not equate to behavior change (Burke, Sherr & Lipman, 2014; Duncan 
et al., 2011). Certified diabetes educators (CDEs) are a specialized group of healthcare 
professionals (most commonly registered nurses, RDs, and pharmacists) that have been trained to 
apply models of behavior change in the care for patients with diabetes (Burke, Sherr & Lipman, 
2014; Duncan et al., 2011). While PCPs and nephrologists should and often do provide patients 
with information about their disease and care plans, these types of encounters typically do not 
provide adequate time to deliver behavior change coaching individualized to their patients’ needs 
(Burke, Sherr & Lipman, 2014; Duncan et al., 2011).  
By incorporating CDEs into the patient’s care team, patients are devoted time to receive 
further explanation of medications, additional monitoring, and coaching to incorporate exercise, 
adhere to medications, optimize diet, adopt healthy coping, and reduce risk that is individualized 
to the patient’s personal goals and needs (Burke, Sherr & Lipman, 2014; Duncan et al., 2011). 
Furthermore, CDEs are trained to assist patients in problem solving of specific barriers by 
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coordinating solutions to food insecurity, physical, emotional, cognitive, and financial obstacles 
(Burke, Sherr & Lipman, 2014). Through this approach, CDEs can tailor support for patients, 
encouraging self-efficacy in managing their disease and achieve the fundamental outcome of 
behavior change (Burke, Sherr & Lipman, 2014). Nephrology patients who successfully 
incorporate behavior change derived from this patient-centered approach have been shown to 
have better sustainability of the behavior change and improved glycemic control that in turn have 
a positive impact on renal disease morbidity and mortality (Alhamad, Cheng, & Vijayan, 2021; 
Burke, Sherr & Lipman, 2014; Duncan et al., 2011; Shurraw et al., 2011).  
Preparation for ESRD. 
Another aspect of multidisciplinary CKD management is ESRD preparation. Shortly after 
CKD diagnosis, patients should be provided anticipatory guidance and counseling to convey 
typical disease course and ESRD management strategies specific to the patient’s risk and needs 
(Alhamad, Cheng, & Vijayan, 2021; Bleyer, 2020; Norman, 2020). The purpose of discussing 
these topics early in disease course is to ensure patients are adequately informed and prepared to 
participate in timely shared decision making for ESRD management should kidney dysfunction 
progress (Alhamad, Cheng, & Vijayan, 2021; Bleyer, 2020; NIDDK, 2017).   
While RRT is typically not initiated until patients reach a GFR of 10 to 15 mL/min, an 
ESRD education course should be provided when GFR reaches 30 mL/min or lower as the 
instigation of dialysis and renal transplant is a lengthy process involving various members of the 
care team (Alhamad, Cheng, & Vijayan, 2021; Bleyer, 2020; NIDDK, 2017; Norman, 2020). 
These educational programs should provide thorough education for the patient and their support 
system regarding ESRD treatments options: HD, HHD, PD, renal transplant, and palliative care 
(Alhamad, Cheng, & Vijayan, 2021; Berns, 2020; Bleyer, 2020; NIDDK, 2017; Norman, 2020). 
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Furthermore, to provide comprehensive preparation, consultation with RDs, CDEs, and social 
workers should be incorporated so that patients and their support systems are activated to make 
informed decisions and behavior changes (Alhamad, Cheng, & Vijayan, 2021; Beerendrakumar, 
Ramamoorthy & Haridasan, 2018; Berns, 2020; Bleyer, 2020; Kalantar-Zadeh, 2013; Paes-
Barreto et al., 2013).  
Should patients choose to pursue renal transplant, they should be referred to a 
multidisciplinary nephrology clinic that specializes in transplant care (Alhamad, Cheng, & 
Vijayan, 2021; Bleyer, 2020). Typically, patients cannot be listed to receive a kidney transplant 
until their GFR reaches 20 mL/min or lower (Alhamad, Cheng, & Vijayan, 2021). However, 
consultation with a specialty transplantation team is encouraged earlier in disease course if 
patients are eligible and interested in pursuing this treatment (Alhamad, Cheng, & Vijayan, 2021; 
Bleyer, 2020).  
Timing and type of RRT initiation is a difficult shared decision that should be 
individualized to the patient’s GFR, presence of uremic symptoms, goals of care, preference, risk 
for poor outcomes, level of independence, supportive factors, and barriers (Alhamad, Cheng, & 
Vijayan, 2021; Bleyer, 2020). If patients are interested in pursuing HD, they should have early 
referral to a vascular surgeon (typically at a GFR of 30 mL/min) for vascular mapping and 
planning for timely placement of dialysis access (Alhamad, Cheng, & Vijayan, 2021; Berns, 
2020; Bleyer, 2020). If PD is preferred, patients should be referred for specialized surgical 
evaluation when they reach a GFR of 30 mL/min, so they can receive timely placement of a 
catheter (Alhamad, Cheng, & Vijayan, 2021; Pirkle, 2019). 
Rural Community Implications 
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Delivering and coordinating CKD standard of care can be challenging in rural and remote 
areas (Koraishy & Rohatgi, 2020; Osman et al., 2017; Rodriguez, Hotchkiss & O’Hare, 2014; 
Smith, Humphreys & Wilson, 2008; Yan et al., 2014). While racial, social, and economic 
inequities have been thoroughly evidenced to impair clinical outcomes in nephrology patients, 
examining these factors in the context of rural-urban differences can be difficult (Rodriguez, 
Hotchkiss & O’Hare, 2014; Smith, Humphreys & Wilson, 2008).  
Characteristics of rural regions in the U.S. tend to compound structural and social 
inequities in healthcare access and outcomes (Koraishy & Rohatgi, 2020; Osman et al., 2017; 
O’Hare, Johansen & Rodriguez, 2006; Rodriguez, Hotchkiss & O’Hare, 2014; Smith, 
Humphreys & Wilson, 2008; Yan et al., 2014). This phenomenon is postulated to arise from 
relative resource isolation, limited transportation, and widely dispersed healthcare facilities 
(Koraishy & Rohatgi, 2020; Osman et al., 2017; Rodriguez, Hotchkiss & O’Hare, 2014; Smith, 
Humphreys & Wilson, 2008; Yan et al., 2014). These added barriers to access are important 
determinants of health outcomes in both treatment and prevention of disease (Rodriguez, 
Hotchkiss & O’Hare, 2014; Smith, Humphreys & Wilson, 2008; Yan et al., 2014). This concept 
is supported by measured disparities of RD care in rural areas, poorer outcomes as distance from 
nephrology clinics increase, and lower rates of pre-ESRD care, all of which become more 
inequitable for non-white or lower income rural residents (Chang et al., 2020; Koraishy & 
Rohatgi, 2020; Osman et al., 2017; Rodriguez, Hotchkiss & O’Hare, 2014; Smith, Humphreys & 
Wilson, 2008; Yan et al., 2014). 
Risk for poor renal health that is commonly measured in occupational and lifestyle 
factors may be more prevalent in rural areas as well (Smith, Humphreys & Wilson, 2008). For 
instance, in rural areas, patients are more likely to be employed by industries that have exposure 
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to chemical, biological, physical, and mechanical hazards (Smith, Humphreys & Wilson, 2008). 
Furthermore, lifestyle factors like poor diet, smoking, low levels of exercise, and psychosocial 
stress are more prevalent in rural areas (Smith, Humphreys & Wilson, 2008; Rodriguez, 
Hotchkiss & O’Hare, 2014). While socioeconomic deprivation and racial inequity are more 
strongly associated with poor renal outcomes than rurality, the high level of heterogeneity in 
U.S. rural territories could affect national statistical analysis of this issue (Koraishy & Rohatgi, 
2020; Osman et al., 2017; Smith, Humphreys & Wilson, 2008; Rodriguez, Hotchkiss & O’Hare, 
2014; Yan et al., 2014) 
Progression to ESRD has been found to occur at higher rates in rural parts of the U.S. 
when compared to urban areas (Smith, Humphreys & Wilson, 2008). As previously discussed, 
providing early and evidence-based CKD management strategies requires time and resource 
intensive care. The disproportionate rates of ESRD in rural areas could arise from trait barriers in 
these regions that impede access to these intensive quality health services (Rodriguez, Hotchkiss 
& O’Hare, 2014; Smith, Humphreys & Wilson, 2008). Patients with kidney disease who live 
substantial distances from a nephrology practice are more likely to have missed appointments 
and receive less treatment compared to those that live closer (Koraishy & Rohatgi, 2020). 
Consequently, these geographically isolated patients are also more likely to be hospitalized and 
experience mortality at higher rates (Koraishy & Rohatgi, 2020). Additionally, while 
nephrologists practicing in rural areas are no less superior than their urban counterparts, the ratio 
of provider to patients can be highly disparate in regions with relative resource isolation, raising 
concern for nonoptimal workforce distribution (Rodriguez, Hotchkiss & O’Hare, 2014).   
Although almost one-fourth of new dialysis patients reside in rural areas, distance 
between patients and dialysis centers are substantially greater than in metropolitan regions 
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(O’Hare, Johansen & Rodriguez, 2006; Rodriguez, Hotchkiss & O’Hare, 2014). Because most 
dialysis centers operate in a capitalistic framework, these private companies evaluate densities of 
patients requiring RRT to select location and number of facilities to maintain an economically 
sustainable patient volume (O’Hare, Johansen & Rodriguez, 2006; Rodriguez, Hotchkiss & 
O’Hare, 2014; Yan et al., 2014). In more remote areas, this leads to fewer dialysis centers and 
central locality which in turn, results in longer commute times (Rodriguez, Hotchkiss & O’Hare, 
2014; Yan et al., 2014). For those initiating dialysis, adjusted death rate has been found to be 
significantly higher in those living further away from their facility (Koraishy & Rohatgi, 2020; 
Osman et al., 2017). Furthermore, rural dialysis facilities are markedly less likely to offer PD or 
HHD training than urban facilities, despite travel distance being an issue for many of their 
patients (O’Hare, Johansen & Rodriguez, 2006). 
Renal transplant is the most effective treatment for ESRD (Rodriguez, Hotchkiss & 
O’Hare, 2014; Yan et al., 2014; Tonelli et al., 2009). However, access to transplantation services 
in rural areas may be compromised (Rodriguez, Hotchkiss & O’Hare, 2014; Yan et al., 2014). 
While some studies have shown that rurality alone is not a strong determinant in access to 
transplantation, areas of lower socioeconomic status and non-white racial groups living in rural 
areas are associated with lower rates of live donor renal transplant (O’Hare, Johansen & 
Rodriguez, 2006; Rodriguez, Hotchkiss & O’Hare, 2014; Tonelli et al., 2009). Black patients 
with ESRD living in rural areas experience lower rates of renal transplant than any other group 
(O’Hare, Johansen & Rodriguez, 2006). Patients of all races in rural areas are more likely to live 
further distances away from specialty transplant clinics and have fewer transportation options 
which are known barriers to healthcare access (Koraishy & Rohatgi, 2020; O’Hare, Johansen & 
TELENEPHROLOGY  30 
Rodriguez, 2006; Osman et al., 2017; Rodriguez, Hotchkiss & O’Hare, 2014; Smith, Humphreys 
& Wilson, 2008; Yan et al., 2014). 
Telenephrology in rural spaces. 
Recent estimates for the U.S. suggest that 96% of adult Americans own a cellphone, 81% 
own a smartphone, three-quarters own a desktop or laptop, and nine out of ten adults regularly 
use the internet (Pew Research Center, 2019). While some small variations exist between factors 
of age, race, income, education and whether someone resides in a rural or urban area, Americans 
are connected to the world of digital information now more than ever (Pew Research Center, 
2019). This preexisting infrastructure has ultimately allowed for implementation of virtual care 
services across the nation with the adoption of new policy through the CARES Act. However, 
even prior to the pandemic, strategies to incorporate telehealth in rural communities have shown 
benefit in patient outcomes, patient and provider satisfaction, and improved access to care 
(Osman et al., 2017; Tuot & Boulware, 2017; Zhai et al., 2014). 
In the pre-pandemic era, the United States’ familiarity and application of telehealth 
services was largely limited to rural health institutions and single payer systems like Indian 
Health Services (IHS) & Veterans Health Administration (VHA) (Osman et al., 2017; Rohatgi, 
Ross & Majoni, 2017). Through the 2018 Bipartisan Act, the beginnings of telenephrology 
policy advancement were realized so that beneficiaries of Medicare Advantage plans and 
Medicare Shared Savings Program could expect to use virtual care services from their homes 
starting in 2020 (Lazur, Bennett & King, 2019). Specific to the field of nephrology, the 
Bipartisan Act stipulated that starting in 2019, patients with ESRD would be allowed to receive 
virtual care services while at home so long as certain conditions were met (Lazur, Bennett & 
King, 2019). While steps were being taken to expand telenephrology services prior to the 
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pandemic, there was still a dearth of adoption due to poor reimbursement and regulatory issues 
(Jain, Ahmad & Wallace, 2020). 
Despite having obstacles to widespread adoption of telenephrology services before the 
pandemic, studies measuring outcomes in settings where it had been implemented, illustrated its 
benefit. Analysis of the VHA, a single-payer system that provides care to nearly 9 million 
veterans, 3 million of whom live in rural communities, has shown that patients who received 
nephrology care via video conferencing maintained clinical outcomes that were at least 
equivalent to in-person care while improved patient adherence to scheduled appointments and 
cost-effectiveness were observed in patients utilizing telenephrology (Osman et al., 2017; 
Rohatgi, Ross & Majoni, 2017).  
With the spread of SARS-CoV-2, the Coronavirus Aid, Relief, and Economic Security 
(CARES) Act and its $2.3 trillion stimulus was signed into law on March 27, 2020. Through the 
CARES Act, Section 3705, statutory requirements for nephrologists to conduct a face-to-face 
evaluation of new and home dialysis patients before use of virtual care services were eliminated 
(Jain, Ahmad & Wallace, 2020; White & Kribs, 2020). Additionally, the CARES Act and 
Centers for Medicare and Medicaid Services (CMS) 1135 waiver adopted coding so that both 
new and existing patients would be eligible to use virtual care services and made full 
reimbursement for both telephone and video visits possible (White & Kribs, 2020). For patients 
using dialysis, this Act further allowed for in-center dialysis units to be sites that perform 
telehealth visits (Jain, Ahmad & Wallace, 2020). Private payers have principally followed suit 
and access to telenephrology services that previously appeared to be a chimera came to fruition 
overnight (Agarwal, 2020; Jain, Ahmad & Wallace, 2020).  
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Outside of virtual points of care with patients, interprofessional use of telehealth 
modalities in rural areas has also been shown to improve health outcomes for patients and 
provider satisfaction (Hardy et al., 2019; Tuot & Boulware, 2017; Winocour et al., 2020). In 
rural regions where there is a relative scarcity of nephrologists, RDs, and CDEs, PCPs may be 
unable to connect patients with vital specialized care in a timely manner. With the 
implementation of virtual interprofessional meetings, PCPs can access nephrology consultant 
services for appraisal of patient panels, receive suggestions for management and have questions 
fielded (Hardy et al., 2019; Winocour et al., 2020). These modalities have been shown to 
improve PCP satisfaction and increase access to specialized nephrology care for patients who 
historically experienced barriers specific to their rural community (Hardy et al., 2019; Winocour 
et al., 2020). 
Theoretical Framework 
 
Based on Kurt Lewin’s Change Theory, this project aims to examine and plan for change 
with the nephrology clinical process. Lewin's model utilizes an unfreezing-change-refreeze 
analysis (Lewin Change Theory, 2020). In this theory, driving, restraining, and equilibrium 
forces are assessed (Lewin Change Theory, 2020).  
Driving forces are those that instigate change to occur and cause a shift in equilibrium 
(Lewin Change Theory, 2020). When driving forces increase over the sum of restraining forces, 
equilibrium is changed (Kaminski, 2011; Lewin Change Theory, 2020). This is the first step in 
the unfreezing process for change to occur (Kaminski, 2011; Lewin Change Theory, 2020). In 
the context of the Change Theory framework, change involves capitalizing on new thoughts, 
feelings, and behaviors so barriers or restraining forces can be approached from a fresh 
perspective. While overcoming individual resistance and group conformity is typically difficult 
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and laborious, the driving forces of the COVID-19 pandemic were so strong that an equilibrium 
shift was inevitable (Lewin Change Theory, 2020).  
U.S. nephrology clinics and their patients are presently in step two of the Change Theory, 
where the change has occurred. The unprecedented rate of a substantial change adoption left 
potential for barriers and restraining forces to remain within the phenomenon. This project aims 
to examine the remaining barriers to successful delivery of telenephrology services and propose 
a plan to ameliorate obstacles and progress towards meaningful, equitable refreezing of new 
practices and behaviors. 
Review of literature 
Telenephrology 
A PubMed and Google Scholar search was performed with the key words “kidney 
disease”, “remote”, “rural”, “telehealth”, “dialysis”, “nephrology”, “end stage Renal disease” and 
“telemedicine” between 2000 and 2021. This was followed by a search of Journal of Medical 
Internet Research publications using the same key words between 2000 and 2021. Articles 
examining the implementation of telenephrology services were specifically examined. There 
were 52 articles deemed appropriate for this review and included in this section. 
 In reviewing the available telenephrology literature, various limitations of the evidence 
were realized. A relatively obvious limitation of the available literature is the novelty of virtual 
care delivery. This resulted in a dearth of large-scale and high-quality investigations of 
telenephrology interventions. Of the telenephrology studies available, the designs, aims, and 
findings are exceedingly heterogenous. While telenephrology programs have been more widely 
adopted in countries with universal healthcare like Canada and Australia, generalizing their cost 
effectiveness findings to the private health insurance dominated U.S. healthcare system is 
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challenging. Additionally, telenephrology policy, reimbursement, barriers, and culture have 
changed dramatically in reaction to the COVID-19 pandemic. The present proximity to this 
catalyst event results in a paucity of telenephrology research that has been conducted within the 
pandemic phenomenon. Consequently, the current evidence for telenephrology interventions 
remains insufficient to develop nationally standardized guides for practice. As such, this review 
of the literature examines the available evidence and reports pertinent findings to direct 
implementation and evaluation of telenephrology programs during and beyond the pandemic 
paradigm in rural regions of Western Washington State. See Tables 4 through 7 within Appendix 
D for a summary of forty-five telenephrology interventions included in the literature review. 
Diversity of telenephrology application. 
Applications of telenephrology have mirrored the diverse and multidisciplinary nature of 
care for the patient with renal disease. From medication reminders to renal transplant 
interventions, telehealth modalities have been applied to improve access to timely care and 
optimize patient-centeredness (Colbert, Venegas-Vera & Lerma, 2020; Koraishy & Rohatgi, 
2020; Osman et al., 2017; Tuot & Boulware, 2017). The types of telehealth modalities applied to 
the field of nephrology can be divided into live (synchronous) and asynchronous domains. Live 
domains include videoconferencing and phone calls while asynchronous domains include store-
and-forward, remote patient monitoring or mobile health (mHealth) applications (Colbert, 
Venegas-Vera & Lerma, 2020; Koraishy & Rohatgi, 2020; Lazur, Bennett & King, 2019; Osman 
et al., 2017; Tuot & Boulware, 2017). See Table 2 within Appendix C for a summary of 
telenephrology formats, their application, advantages, and disadvantages. 
Aspects of nephrology care have been efficiently deployed through mobile phones using 
text messaging, smart phone apps, phone calls and patient portal applications (Blakeman et al., 
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2014; Diamantidis et al., 2012; Hayashi et al., 2017; McGillicuddy et al., 2013; Ong et al., 2016; 
Salgia et al., 2014; Stark et al., 2011). Several studies have examined the use mobile phone 
functions to provide patient education, community resources, medication safety information, 
medication, and appointment reminders (Blakeman et al., 2014; McGillicuddy et al., 2013; Ong 
et al., 2016; Reese et al., 2017; Salgia et al., 2014; Singh et al., 2019; Stark et al., 2011). 
Alternatively, one smart phone app, Self-Management and Recording System for Dialysis 
(SMARTD), was developed to support patients in completing their own dialysis monitoring 
(Hayashi et al., 2017). Through this app, dialysis users were enabled to self-monitor weight, 
serum potassium, and serum phosphorus at home (Hayashi et al., 2017). Another smart phone 
app was developed to encourage health promoting behaviors in patients with advanced CKD 
(Ong et al., 2016). Through the application, patients are prompted to monitor their blood 
pressure, manage medications, self-assess symptoms, and track their laboratory results (Ong et 
al., 2016). In addition to phone-based applications, web-based programs have been used as 
vehicles to deliver nephrology education and resources (Diamnatidis et al., 2013; Malkina & 
Tuot, 2018; Osman et al., 2017). One example is the VA’s e-Kidney Clinic as an educational 
tool, designed for patients at any stage of CKD (Malkina & Tuot, 2018). Since the program’s 
launch in 2013, the website traffic has tripled, illustrating demand for this type of educational 
platform (Koraishy & Rohatgi, 2020; Lederer et al., 2015; Malkina & Tuot, 2018) 
The adoption of synchronous patient-to-provider telenephrology visits over telephone or 
videoconference has grown rapidly in response to the COVID-19 pandemic (Koraishy & 
Rohatgi, 2020). Historically, the majority of telenephrology encounters in the U.S. were made 
possible through programs implemented by the VA system, IHS, and rural healthcare networks 
(Crowley et al., 2017; Gasparini et al., 2019; Koraishy & Rohatgi, 2020; Osman et al., 2017; 
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Shen et al., 2019; Tuot & Boulware, 2017). The VA has pioneered various telenephrology 
modalities, including Renal Clinical Video Telehealth (CTA) (Crowley et al., 2017; Lederer et 
al., 2015; Malkina & Tuot, 2018; McAdams, Cannavo, & Orlander, 2014; Salgia et al., 2014; 
Tan et al., 2017). Renal CTA was developed to reach geographically remote veterans with 
kidney disease through the use of video encounters and remote monitoring devices (i.e., 
sphygmomanometer, scale, ultrasound) (Crowley et al., 2017; Koraishy & Rohatgi, 2020; Tan et 
al., 2017). This program was designed to function in a multitude of settings including hospital-
to-hospital, hospital-to-clinic, and hospital-to-home, depending on the location of the patient 
(Crowley et al., 2017; Koraishy & Rohatgi, 2020; Tan et al., 2017).  
Internationally, telenephrology encounters have been widely adopted as a way to deliver 
care (Koraishy & Rohatgi, 2020). In the mid-1990s, Australia adopted telenephrology encounters 
to reach remote aboriginal populations and dialysis units, first through telephone, then through 
videoconferencing as technology advanced (Koraishy & Rohatgi, 2020; Michell et al., 1997; 
Mitchel et al., 2000). In Canada, remote management of patients using hemodialysis was 
adopted in the 1980s (Koraishy & Rohatgi, 2020; Ovtcharenko & Thomson, 2019). Since its 
infancy, these telenephrology encounters have advanced from telephone calls and faxes to 
videoconferencing and telerounds to bridge high-quality care to isolated rural communities 
(Beiber & Weiner, 2018; Berstein et al., 2008; Ovtcharenko & Thomson, 2019; Sicotte et al., 
2011).  
A growing body of evidence has reflected better rates of survival, cost-effectiveness, and 
quality of life with home dialysis compared to in-center dialysis, especially for patients residing 
in rural communities (Beiber & Weiner, 2018; Lew & Sikka, 2019; Mailloux & Blagg, 2016; 
Whitlow & Wallace, 2019). This along with advances in remote monitoring devices has made 
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HHD and home-PD an increasingly desirable choice to both patients and providers (Berman et 
al., 2011; Kiberd et al., 2018; Kooman et al., 2020; Lew & Sikka, 2019; Mailloux & Blagg, 
2016; Malkina & Tuot, 2018; Whitlow & Wallace, 2019). Internationally and nationally, various 
home-dialysis telenephrology programs have been adopted to improve access and efficiency in 
the highly resource intensive intervention of RRT (Bernstein et al., 2010; Hayashi et al., 2017; 
Kiberd et al., 2018; Kooman et al., 2020; Lew & Sikka, 2019; Lunney et al., 2018; Mailloux & 
Blagg, 2016; Malkina & Tuot, 2018; Shen et al., 2019; Sicotte et al., 2011; Whitlow & Wallace, 
2019). These home-dialysis telenephrology interventions can include virtual encounters, 
education and training programs, remote monitoring, and ancillary services (Ensell, 2017; 
Hayashi et al., 2017; Kiberd et al., 2018; Kooman et al., 2020; Lew & Sikka, 2019; Lunney et 
al., 2018; Mailloux & Blagg, 2016; Malkina & Tuot, 2018; Sicotte et al., 2011; Stark et al., 
2011; Wallace et al., 2017; Whitlow & Wallace, 2019). 
Telenephrology programs tailored to patients who could benefit from or who have 
received renal transplant are growing in utilization (Cabacungan et al., 2018; McGillicuddy et 
al., 2013; Reese et al., 2017). These programs include pre-transplant education and resources, 
and post-transplant medication adherence, blood pressure control, and immune suppressive 
therapy maintenance (Cabacungan et al., 2018; McGillicuddy et al., 2013; Reese et al., 2017). 
While many telenephrology programs direct interventions with patients, virtual provider-
to-provider interventions have been utilized in the field of nephrology as well (Ensell, 2017; 
Hardy et al., 2019; Lea & Tannenbaum, 2020; McAdams et al., 2014; Salgia et al., 2014; 
Winocour et al., 2020). The majority of interprofessional telenephrology applications have been 
deployed to rural or remote areas where there is a dearth of nephrology providers (Ensell, 2017; 
Hardy et al., 2019; Lea & Tannenbaum, 2020; McAdams et al., 2014; Salgia et al., 2014; 
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Winocour et al., 2020). Examples of these programs include the VA’s eConsult and SCAN-
ECHO (Specialty Care Access Network – Extension of Community Healthcare Outcomes) 
programs, Sanderling Renal Services, and ENHIDE (East and North Herts Institute of Diabetes 
and Endocrinology) diabetes renal telehealth (Hardy et al., 2019; Lea & Tannenbaum, 2020; 
McAdams et al., 2014; Salgia et al., 2014; Winocour et al., 2020). 
Executing large-scale screening programs to identify patients who could benefit from 
nephrology care has historically been a huge undertaking (Shlipak et al., 2021). With the advent 
of artificial intelligence (AI) applications, patient data can be used to efficiently screen patient 
panels for at-risk individuals (Hao et al., 2017; Sheng et al., 2020; Song et al., 2020). Using 
telenephrology modalities, social marketing of prevention and screening campaigns could be 
efficiently distributed to patients with high-risk for renal disease through mHealth and patient 
portal technology (Osman et al., 2017; Shlipak et al., 2021; Swee et al., 2020; Tuot et al., 2020).  
In reviewing various examples of telenephrology delivery, the literature collectively 
serves as evidence that each application should be evaluated in its respective context. 
Consideration of the study quality, sample population (age, race, comorbidities, in-patient vs. 
out-patient, and stage of CKD), intended use, and outcomes will allow for more meaningful 
telenephrology program guidance.  
Benefits of telenephrology. 
Implementation of telenephrology allows for capitalizing on the flexible, adaptable, and 
accessible nature of virtual care services to mitigate barriers in rural communities while 
harboring the potential to improve health outcomes of nephrology patients in a cost-effective 
way (Batsis et al, 2019; Ensell, 2017; Crowley et al., 2017; Koraishy & Rohatgi, 2020; Lea & 
Tannenbaum, 2020; McAdams et al., 2014; Osman et al., 2017; Tan et al., 2017; Tuot & 
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Boulware, 2017; Wallace et al., 2017; Whitlow & Wallace, 2019; Zhai et al., 2014). Given the 
heterogenous nature of telenephrology studies, evidence of their benefit is examined by intended 
use as well as primary and secondary outcome measures. 
Telenephrology modalities adopted outside of the clinical delivery process have been 
widely studied. Development of educational and behavioral telehealth interventions tailored to 
nephrology patients are presumably less of a logistical endeavor than adapting clinical care 
delivery as their utility does not hinge on policy and reimbursement. Nevertheless, these 
modalities harbor potential for benefits in patient outcomes (Blakeman et al., 2014; Diamantidis 
et al., 2012; Diamantidis et al., 2013; Malkina & Tuot, 2018; McGillicuddy et al., 2013; Ong et 
al., 2016; Stark et al., 2011; Tuot et al., 2020). Smartphone apps and web-based portals have 
been used to improve patient knowledge and awareness, encourage positive behaviors, provide 
community support, encourage self-monitoring and self-management, medication adherence, and 
appointment adherence (Blakeman et al., 2014; Bowman et al., 2020; Cabacungan et al., 2018; 
Chang et al., 2020; Diamantidis et al., 2018; Diamantidis et al., 2013; Diamantidis et al., 2012; 
Donald et al., 2021; Dubin & Rubinsky, 2019; El Khoury et al., 2020; Ellis et al., 2019; Fink et 
al., 2016; Hayashi et al., 2017; Kaiser et al., 2020; Kiberd et al., 2018; Kobe et al., 2020; Kyte et 
al., 2020; Li et al., 2020; Liu et al., 2017; Malkina & Tuot, 2018; McGillicuddy et al., 2013; 
Minatodoni & Berman, 2013; Ong et al., 2016; Reddy & Aronoff, 2016; Reese et al., 2017; Som 
et al., 2011; Stark et al., 2011; Swee et al., 2020; Tuot et al., 2020; Warner et al., 2018). These 
interventions have been measured to improve blood pressure, patient self-efficacy, patient 
decision-making, diet, behaviors, rates of hospitalization, rates of missed appointments, lab 
values, safety, weight, and patient satisfaction (Blakeman et al., 2014; Bowman et al., 2020; 
Cabacungan et al., 2018; Chang et al., 2020; Diamantidis et al., 2018; Diamantidis et al., 2013; 
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Diamantidis et al., 2012; Donald et al., 2021; Dubin & Rubinsky, 2019; El Khoury et al., 2020; 
Ellis et al., 2019; Fink et al., 2016; Hayashi et al., 2017; Kaiser et al., 2020; Kiberd et al., 2018; 
Kobe et al., 2020; Kyte et al., 2020; Li et al., 2020; Liu et al., 2017; Malkina & Tuot, 2018; 
McGillicuddy et al., 2013; Minatodoni & Berman, 2013; Ong et al., 2016; Reddy & Aronoff, 
2016; Reese et al., 2017; Som et al., 2011; Stark et al., 2011; Tuot et al., 2020; Warner et al., 
2018). Furthermore, many of these interventions proved to be cost-effective when accounting for 
their outcomes (Blakeman et al., 2014; Chang et al., 2020; Dubin & Rubinsky, 2019; Ellis et al., 
2019; Fink et al., 2016; Hayashi et al., 2017; Ong et al., 2016; Song et al., 2020; Swee et al., 
2020; Tuot et al., 2020; Warner et al., 2018). 
Adoption of synchronous telenephrology modalities for care delivery through 
videoconference or telephone visits has proven to be feasible, patient-centered, and effective 
(Belcher, 2020; Blakeman et al., 2014; Chang et al., 2020; Ishani et al., 2016; Kaiser et al., 
2020; Kelly et al., 2018; Kiberd et al., 2018; Ensell, 2017; Ladino et al., 2016; Rohatgi, Tan & 
Mehrotra, 2018; Sicotte et al., 2011; Swee et al., 2020; Tan et al., 2018; Whitten & Buis, 2008). 
Regardless of disease stage or severity, providing the option for virtual or telephone visits with 
specialized members of the nephrology care team can improve patient outcomes and experience 
(Blakeman et al., 2014; Chang et al., 2020; Ishani et al., 2016; Kaiser et al., 2020; Krishna et al., 
2016; Kelly et al., 2018; Kiberd et al., 2018; Ensell, 2017; Ladino et al., 2016; Rohatgi, Tan & 
Mehrotra, 2018; Sicotte et al., 2011; Swee et al., 2020; Tan et al., 2018; Whitten & Buis, 2008). 
The benefit of these services is often amplified for patients who experience geographical or 
socioeconomic barriers to care (Chang et al., 2020; Ishani et al., 2016; Kelly et al., 2018; 
Krishna et al., 2016; Ensell, 2017; Ladino et al., 2016; Rohatgi, Tan & Mehrotra, 2018; Sicotte 
et al., 2011; Swee et al., 2020; Tan et al., 2018; Whitten & Buis, 2008). For example, a VA 
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health system in Iowa innovatively linked telenephrology modalities to survey their patient panel 
for patients at risk for kidney disease to then provide early virtual nephrology consultation (Swee 
et al., 2020). This particular patient panel experienced rural and geographical barriers to 
nephrology care. Through this intervention, 459 of 1,284 patients were detected to be at risk for 
kidney disease and were provided access to nephrology services early in their disease course 
(Swee et al., 2020). The study found that with this intervention, patients saved between $21.60 
and $63.90 per trip by using virtual consult, workflow was made to be more efficient, and rates 
of early detection and identification of disease were improved (Swee et al., 2020). 
Randomized control trials (RCT) investigating the effectiveness of telenephrology visits 
have shown that virtual and telephone encounters meet or exceed patient outcomes seen in 
standard in-person care (Berman et al., 2011; Blakeman et al., 2014; Ishani et al., 2016; Kelly et 
al., 2018; Kobe et al., 2020; Minatodoni & Berman, 2013). Furthermore, providers and 
institutions frequently benefit from reduced travel time to facilities, cost savings from 
appointment adherence and fewer emergency or in-patient care needs, and efficient patient 
workflow (Crowley et al., 2017; Ishani et al., 2016; Kelly et al., 2018; Krishna et al., 2016; 
Ensell, 2017; Ladino et al., 2016; Pichler et al., 2016; Rohatgi, Tan & Mehrotra, 2018; Sicotte et 
al., 2011; Swee et al., 2020; Tan et al., 2018; Whitten & Buis, 2008).  
For patients with ESRD, telenephrology offers substantial benefit in access to care, 
clinical outcomes, and quality of life (Beiber & Weiner, 2018; Dubin & Rubinsky, 2019; Ensell, 
2017; Hayashi et al., 2017; Kaiser et al., 2020; Kiberd et al., 2018; El Koury et al., 2020; 
Krishna et al., 2016; Reddy & Aronoff, 2016; Sicotte et al., 2011; Whitten & Buis, 2008). This is 
especially true for patients living in rural communities (Beiber & Weiner, 2018; Dubin & 
Rubinsky, 2019; Ensell, 2017; Hayashi et al., 2017; Kaiser et al., 2020; Kiberd et al., 2018; El 
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Koury et al., 2020; Krishna et al., 2016; Reddy & Aronoff, 2016; Sicotte et al., 2011; Thompson 
et al., 2012; Whitten & Buis, 2008; White & Kribs, 2020). Of all chronic diseases, ESRD 
therapies prove to be the most disruptive to patients’ lives requiring daily time- and resource-
intensive interventions (Lew et al., 2020; Thompson et al., 2012; Wallace et al., 2017; White & 
Kribs, 2020). Moving RRT into the patient’s home not only improves quality of life but also 
affords significant improvement in clinical outcomes and cost-savings (Burkart, 2019; Bernstein 
et al., 2010; Colbert, Venegas-Vera & Lerma, 2020; Dubin & Rubinsky, 2019; Kaiser et al., 
2020; Kiberd et al., 2018; Krishna et al., 2016; Glickman & Chan, 2021; Lew et al., 2020; 
Mailloux & Blagg, 2016; Moist et al., 2008; Wallace et al., 2017). Furthermore, with advances 
in technology patients can now use remote monitoring devices to make home-based disease 
assessment and management more comprehensive (Berman et al., 2011; Colbert, Venegas-Vera 
& Lerma, 2020; Hayashi et al., 2017; Kooman et al., 2020; Liu et al., 2017; Minatodoni & 
Berman, 2013; Reddy & Aronoff, 2016; White & Kribs, 2020; Whitlow & Wallace, 2019). 
Studies have shown adding remote monitoring devices to home dialysis therapy can improve 
individualization of therapy, number of hospitalizations, number of emergency department (ED) 
visits, patient perception of provider co-presence, and provider satisfaction (Berman et al., 2011; 
Hayashi et al., 2017; Liu et al., 2017; Minatodoni & Berman, 2013; Reddy & Aronoff, 2016; 
White & Kribs, 2020; Whitlow & Wallace, 2019). One RCT measured a $91,000 savings in 
hospital and ED charges by adding remote monitoring to HHD care (Berman et al., 2011; 
Minatodoni & Berman, 2013).  
While renal transplant is the most effective intervention for treatment of ESRD, rates of 
transplantation in the U.S. are significantly lower than RRT (Bello et al., 2012; Cabacungan et 
al., 2018; O’hare, Johansen & Rodriguez, 2006; Tonelli et al., 2006;). Of all ESRD patients, 
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Black Americans living in rural areas have the lowest rates of receiving renal transplant and are 
more likely to receive kidneys from deceased doners than living (Bello et al., 2012; Cabacungan 
et al., 2018; O’hare, Johansen & Rodriguez, 2006; Tonelli et al., 2006). One pilot program 
sought to target rural dwelling African Americans to receive tablet-based education on options 
for live donor kidney transplant, paired with telephone social worker counseling to improve 
access and support decision making in this at-risk population (Cabacungan et al., 2018). 
Participants reported this cost-effective intervention was preferred to in-person education and 
counseling (Cabacungan et al., 2018). Once patients have received a renal transplant, adherence 
to medications and immunosuppressive therapy is paramount to safety and success 
(McGillicuddy et al., 2013; Reese et al., 2017). Studies have shown that by incorporating 
mHealth technology, patients can improve adherence to blood pressure control and 
immunosuppressive therapies (McGillicuddy et al., 2013; Reese et al., 2017).  
Provider-to-provider applications of telenephrology have been shown to be integral in 
improving access to specialty care in rural and resource isolate regions (Beste et al., 2016; 
Colbert, Venegas-Vera & Lerma, 2020; Crowley et al., 2017; Hardy et al., 2019; Pichler et al., 
2016; Salgia et al., 2014; Tuot & Boulware, 2017; Winocour et al., 2020). Nephrologist 
eConsults, mentorship, and patient panel appraisal have proven to be cost-effective, improve 
patient outcomes, and improve provider and specialist satisfaction (Beste et al., 2016; Crowley et 
al., 2017; Hardy et al., 2019; Pichler et al., 2016; Salgia et al., 2014; Winocour et al., 2020). One 
of the first and most expansive adoptions of provider-to-provider telenephrology in the U.S. is 
the VA’s Specialty Care Access Network – Extension of Community Healthcare Outcomes 
(SCAN-ECHO) program (Beste et al., 2016; Crowley et al., 2017; Salgia et al., 2014). The 
Pacific Northwest Veteran Integrated Service Network (VISN) branch serves 135 counties 
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between Alaska, Washington, Oregon, Idaho, Montana, and California (Crowley et al., 2017). 
By adding kidney specialty care to the Seattle and Portland hubs, SCAN-ECHO has successfully 
overcome geographical barriers to care by serving four VA medical centers, 28 VA community-
based outpatient clinics, and twelve VA outreach clinics (Crowley et al., 2017).  
Limitations of adopting telenephrology. 
While telenephrology programs have exhibited potential for benefit, there are essential 
considerations to take when implementing these services. Factors like access to internet, user 
ability and preference, physical exam limitations, literacy and language barriers, infrastructure, 
security, and fragmentation of healthcare are worthy of attention when implementing and 
evaluating telenephrology programs (Batsis et al., 2019; Colbert, Venegas-Vera & Lerma, 2020; 
Koraishy & Rohatgi, 2020; Lew et al., 2021; Osman et al., 2017; Ovtcharenk & Thomson, 2019; 
Tuot & Boulware, 2017). 
Inherently, there is an ethical dilemma to rolling out telenephrology services at a large 
scale. Decades of population health data suggest that marginalized groups of people are at the 
highest risk for developing kidney disease and having more severe outcomes (CDC, 2019; 
Colbert, Venegas-Vera & Lerma, 2020; Jain, Ahmad & Wallace, 2020; Koraishy & Rohatgi, 
2020; Lew et al., 2021; Osman et al., 2017; Rodriguez, Hotchkiss & O’Hare, 2013; Rucker et 
al., 2011; Shlipak et al., 2021; Tonelli et al., 2006; Tuot & Boulware, 2017; Yan et al., 2013). 
However, risk factors for kidney disease may simultaneously overlap with barriers to effective 
use of the many forms of telenephrology (Batsis et al., 2019; Diamantidis & Becker, 2014; 
Lederer et al., 2015; Lew et al., 2021; Osman et al., 2017; Rodriguez, Hotchkiss & O’Hare, 
2013; Sarkar et al., 2011; Shlipak et al., 2021; Yan et al., 2013). For example, patients living in 
rural areas with relative resource isolation are at risk for having poor access to necessary 
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infrastructure (internet, cell coverage and technology devices), limited computer literacy, and 
language barriers (Batsis et al., 2019; Lew et al., 2021; Osman et al., 2017; Rodriguez, 
Hotchkiss & O’Hare, 2013; Sarkar et al., 2011; Shlipak et al., 2021; Yan et al., 2013).  
Many of the larger trials conducted in the U.S. have been completed through the VA 
system. While results from VA telenephrology service implementation support its use in rural 
communities, their sample populations are often overwhelming male and white, raising concern 
for generalizing application to other populations (Beste et al., 2016; Crowley et al., 2017; Dubin 
& Rubinsky, 2019; Ishani et al., 2016; Ladino et al., 2016; McAdams, Cannavo & Orlander, 
2014; Pichler et al., 2016; Rohatgi, Tan & Mehrotra, 2015; Salgia et al., 2014; Swee et al., 2020; 
Tan et al., 2018; Tuot et al., 2020). One study conducted outside of the VA system found older 
adults, those with lower levels of education, African Americans, Latinos and Filipinos are less 
likely to request a password to access their patient portal and are less likely to employ the 
functions of it even if they had (Sarkar et al., 2011). The existing literature serves as evidence 
that many studies exclude patient populations who are most likely to experience care access 
barriers from their samples (Beste et al., 2016; Batsis et al., 2019; Dubin & Rubinsky, 2019; 
Ishani et al., 2016; Ladino et al., 2016; McAdams, Cannavo & Orlander, 2014; Pichler et al., 
2016; Rodriguez, Hotchkiss & O’Hare, 2013; Rohatgi, Tan & Mehrotra, 2015; Salgia et al., 
2014; Sarkar et al., 2011; Yan et al., 2013). This creates challenges in elucidating impact and 
utility of these interventions in the most vulnerable nephrology patient populations.  
There is concern for deploying telenephrology modalities through state-of-the-art 
technology in a patient population that is generally over the age of 65. While many younger 
patients navigate new technologies with ease, older adults may have trouble in obtaining care 
through novel devices (Batsis et al., 2019; Colbert, Venegas-Vera & Lerma, 2020; Koraishy & 
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Rohatgi, 2020; Lew et al., 2021; Osman et al., 2017; Ovtcharenk & Thomson, 2019; Tuot & 
Boulware, 2017). To examine the technology divide, a systemic review of telehealth utilization in 
geriatric patients examined the implication of age to maintaining feasible and acceptable care 
(Batsis et al., 2019). They found that while older adults living in the United States are the fastest 
growing user group of technology, this patient population may be limited by less experience in 
using emerging technologies, considerable age-related barriers (impaired sensory, memory and 
cognitive function), and the presence of multiple co-morbidities that require in-person care 
(Batsis et al., 2019). Ultimately, the review concluded that for older adults living in rural 
communities, access to virtual care services can yield long-term cost-effectiveness and reduce 
hospital utilization and emergency department visits (Batsis et al., 2019). However, there is 
evidence of technological literacy barriers that have strong implications for individualizing 
telenephrology delivery to meet the needs of nephrology patient populations. 
Another limitation to telenephrology is the inability to do a comprehensive physical 
examination as well as an impaired ability to evaluate non-verbal communication. While this 
limitation is a rather obvious notion of virtual care, its implications involve a great deal of 
decision making from health care institutions, healthcare professionals and patients (Batsis et al., 
2019; Colbert, Venegas-Vera & Lerma, 2020; Koraishy & Rohatgi, 2020; Osman et al., 2017; 
Zuniga et al., 2020). For healthcare providers, making clinical decisions to hold encounters 
virtually or in-person involves careful consideration of risk and benefits (Batsis et al., 2019; 
Colbert, Venegas-Vera & Lerma, 2020; Koraishy & Rohatgi, 2020; Osman et al., 2017; Zuniga 
et al., 2020). While there have been advances in developing remote monitoring equipment to aid 
in assessing patients outside of the exam room, there presently is no technology available to 
replace a comprehensive physical exam (Kooman et al., 2020). Ultimately, the liability and 
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responsibility for patient safety falls upon clinicians to make judgments on when virtual care 
services will be unacceptable (Colbert, Venegas-Vera & Lerma, 2020; Koraishy & Rohatgi, 
2020).  
Given the momentum of technological advancement in healthcare and everyday life, 
optimizing care to further incorporate the option for telehealth modalities is inevitable. However, 
routine assessment of the nuanced barriers and limitations to telehealth are essential so their 
operations can appropriately meet the needs of patients and providers and produce equitable 
outcomes for those with the highest risk for poor outcomes. 
Telenephrology infrastructure. 
Successful implementation of telenephrology services requires specific patient population 
and institution infrastructure. Ensuring patients and providers have the access and ability to use 
technological devices for the delivery of telenephrology services is fundamental (Batsis et al., 
2019; Colbert, Venegas-Vera & Lerma, 2020; Koraishy & Rohatgi, 2020; Lew et al., 2021; 
Osman et al., 2017; Ovtcharenk & Thomson, 2019; Sarkar et al., 2011; Tuot & Boulware, 2017; 
Zuniga et al., 2020). Distinct infrastructure requirements heavily depend on the intended use for 
telenephrology services. However, nearly all telenephrology interventions require healthcare 
institution teams to coordinate planning, implementation, and evaluation of the service (Colbert, 
Venegas-Vera & Lerma, 2020; Koraishy & Rohatgi, 2020; Lew et al., 2021). Furthermore, for 
all telenephrology interventions, there must be infrastructure in place to ensure patient 
information is kept private and devices are reliable (Colbert, Venegas-Vera & Lerma, 2020; 
Koraishy & Rohatgi, 2020; Lew et al., 2021).  
To use telenephrology for non-dialysis interventions, much of the needed infrastructure is 
already positioned for use (Bowman et al., 2020; Chang et al., 2020; Diamantidis et al., 2012; 
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Diamantidis et al., 2013; Donald et al., 2021; Ellis et al., 2019; Kelly et al., 2018; Kyte et al., 
2020; Li et al., 2020; Ong et al., 2016; Pew Research Center, 2019). mHealth interventions 
depend on patients having the access and ability to use a mobile phone (Bowman et al., 2020; 
Diamantidis et al., 2012; Diamantidis et al., 2013; Ellis et al., 2019; Kelly et al., 2018; Li et al., 
2020; Ong et al., 2016). With the vast majority of nephrology patients already owning and 
regularly using mobile or smartphone devices, these types of interventions generally do not 
require investment in new infrastructure but rather optimize what already exists (Bowman et al., 
2020; Diamantidis et al., 2012; Diamantidis et al., 2013; Ellis et al., 2019; Kelly et al., 2018; Li 
et al., 2020; Ong et al., 2016; Pew Research Center, 2019). Similarly, web-based interventions 
can often rely on patients having access to a smartphone, computer, and internet or cell service 
(Donald et al., 2021; Fink et al., 2016; Kyte et al., 2020; Li et al., 2020). Institutional 
infrastructure for mHealth and web-based interventions typically require personnel to plan for 
program implementation and evaluation as well as resources to develop websites, apps, and text 
messaging campaigns (Bowman et al., 2020; Chang et al., 2020; Diamantidis et al., 2012; 
Diamantidis et al., 2013; Donald et al., 2021; Ellis et al., 2019; Kelly et al., 2018; Kyte et al., 
2020; Li et al., 2020; Ong et al., 2016).  
To successfully implement synchronous telenephrology services, additional infrastructure 
is needed. While patients typically can rely on existing infrastructure like mobile phones, 
smartphones, landlines, and computers, institutions need to develop policies and plans for 
telephone or videoconference encounters (Chang et al., 2020; Kelly et al., 2018; Lew et al., 
2021; Li et al., 2020; Tan et al., 2018; Wallace et al., 2017). Additionally, institutions may need 
to purchase new software or optimize existing platforms to deploy these services (Lew et al., 
2021; Wallace et al., 2017; Warner et al., 2018). Often, planning for these services will involve 
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assigning roles to institution personnel to provide training and tech support for patients and 
providers (Lew et al., 2021; Wallace et al., 2017). 
Adding remote monitoring devices to patient care introduces another level of 
infrastructure. While some telenephrology interventions opt to have patients use consumer 
accessible devices like store-bought sphygmomanometers, pulse oximeters, or scales, others 
incorporate devices that can transmit data directly to the patient’s EMR (Donald et al., 2021; 
Ellis et al., 2019; Kooman et al., 2020; Lew et al., 2021; Wallace et al., 2017). Regardless of 
choice, institutions are required to consider which devices are Food and Drug Administration 
(FDA) approved and whether investment in more advanced devices is economically feasible 
(Kooman et al., 2020; Lazur, Bennet & King, 2019; Lew et al., 2021; Wallace et al., 2017).  
Furthermore, some telenephrology interventions are designed for providers to be notified if 
patient-monitoring devices detect out of therapeutic range recordings (Lew et al., 2021). This 
requires institutions to develop policies for when and how often this data should be reviewed and 
how providers will be reimbursed for their time.  
For dialysis-focused telenephrology interventions, infrastructure needs become more 
intensive. While patient-managed dialysis largely occurs outside of healthcare facilities, 
personnel and often physical space is required to initiate a home dialysis program (Burkart, 
2019; Glickman & Chan, 2021; Lew et al., 2021; Mailloux & Blagg, 2016; Wallace et al., 2017; 
Young et al., 2012). As PD and HHD training, encounters, and care coordination are similar, it 
may be beneficial to integrate their management within the same physical clinical space and 
processes (Lew et al., 2021; Glickman & Chan, 2021). Regardless of location or process, both 
patients and providers need to be trained to safely operate devices and have necessary equipment 
available (Glickman & Chan, 2021; Lew et al., 2021; Mailloux & Blagg, 2016; Wallace et al., 
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2017; Young et al., 2012). In the United States, HHD programs can be initiated and delivered by 
hospital- or nephrology group-owned facilities, however, the vast majority of outpatient dialysis 
facilities with pre-existing infrastructure are private companies, like DaVita or Fresenius 
(Glickman & Chan, 2021; Levin, Lingam & Janiga, 2020). Thus, development of ESRD 
Seamless Care Organization (ESCO) partnerships between nephrologists, dialysis clinics, and 
suppliers in a contiguous geographical area may prove to be the most cost-effective (Glickman & 
Chan, 2021; Levin, Lingam & Janiga, 2020).  
In the U.S., FDA approved HHD machines include the Fresenius 2008K@home, Tablo 
Hemodialysis system, or NxStage (Glickman & Chan, 2021). The Fresenius 2008K@home 
machine comes with the most stipulations requiring patients to have a care partner, significant 
space for the device, electrical and plumbing modifications, and the ability to cover water and 
electricity costs (Glickman & Chan, 2021). 
Methods 
 This project offers a proposal for implementation and evaluation of telenephrology 
services in rural settings, using the Pan-American Health Organization – World Health 
Organization (PAHO-WHO) Framework for the Implementation of a Telemedicine Service and 
Model for Assessment of Telemedicine Application (MAST) as a guide (Kidholm et al., 2012; 
PAHO-WHO, 2016). Given the heterogenous nature of rural spaces in the U.S., implementation 
and evaluation strategies are presented in a way that allows for adaptation to meet the individual 
needs of nephrology practices operating in rural Western Washington. 
Telenephrology Program Implementation 
 Program implementation begins with a strategic analysis of the context, setting needs, 
culture, and sustainability. This analysis then becomes the foundational guide to organize 
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formation of a coordination team including the necessary authorities, stakeholders, and work 
team. The coordination team works collaboratively towards program implementation through 
planning for policy development, evaluation and monitoring, communication systems, business 
models, technology, infrastructure, legal, and regulatory issues. Once telenephrology services 
have been implemented, evaluation and monitoring of the program commence. See Figure 2 for a 
detailed illustration of these processes with order of operation.  
Given the unique circumstances imposed by the COVID-19 pandemic, many facilities 
have already worked through or bypassed steps in the planning process and are currently offering 
some form of telenephrology service. For institutions at or beyond the service implementation 
phase, these critical steps in program planning can still serve as a guide for building program 
capacity and sustainability for current services, as well as application of new telenephrology 
modalities and practices.  
Logistics 
 Intended use of telenephrology program. 
 The potential application of telenephrology services is highly diverse in scale and 
intended use. Healthcare institutions must assess the needs of their respective patient populations 
to determine which telenephrology services would provide the best outcomes. Furthermore, an 
understanding of the existing healthcare service platforms both inside and outside of network is 
necessary to avoid redundancy and fragmentation. Through careful appraisal, an institution can 
identify the intended use or uses of a telenephrology program. Depending on resources and 
needs, institutions may need to plan for expanding the scale of services over time. 
 Ideally, institutions should strive to deploy telenephrology modalities to execute 
interventions across the span of renal disease severity. In other words, by introducing these 
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services across the spectrum of CKD screening to ESRD management, the potential for 
efficiency, cost-effectiveness, and familiarity increases.  
 Infrastructure. 
 While telenephrology services afford the benefit of avoiding major construction and 
building projects, renovation of devices and systems will likely be required. The necessary 
infrastructure will rely heavily on the intended use of telenephrology services. Capitalizing on 
existing technology and personnel is paramount to cost-effectiveness and efficiency. For 
example, if a nephrology practice wanted to add remote monitoring to an existing home dialysis 
program, ideally the institution’s technical and EMR support services would collaborate with key 
stakeholders to ensure data collected in the patient’s home transmits directly into the existing 
EMR platform. Through this approach, resources are not wasted on transferring data between 
systems, learning a new platform, or recruiting new staff to achieve standard of care.  
 Ethical implications of telenephrology programs should be considered and mitigated for 
early in implementation. Infrastructure for personnel to assess need for language services and 
appraise age-, socioeconomic-, and disability-barriers to access are essential to achieve equitable 
outcomes across the receiving patient population.  
 Special consideration should be given to the reliability and security of new technology. 
Whether an institution is investing in HHD machines, remote monitoring devices, or 
videoconferencing software, ensuring technology meets standards and regulations is paramount. 
Coordination teams should review relevant FDA approval of devices and new technology 
accordance with HIPAA standards to ensure telenephrology services are not compromised. 
 To make sure telenephrology programs realize their full potential, institutions should plan 
for social marketing of new services. Again, this is most efficiently accomplished if institutions 
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can capitalize on pre-existing systems and personnel. For instance, marketing of a new service 
with relevant information and ways to access it could be added to an institution’s website or 
EMR patient portal. 
 Coordination teams should clearly identify roles of its members as well as auxiliary staff. 
Both staff and patients will require adequate training to appropriately deploy and use new 
telenephrology services. Each individual interacting with the new service should be fully aware 
and prepared to carry out their role and responsibilities. Coordination teams should have systems 
in place to regularly communicate implementation phases, outcomes, goals, and future planning. 
Timeline 
 Timeline for telenephrology service implementation will vary greatly depending on each 
institution’s goals for intended use, scale, pre-existing infrastructure, and prior use of 
telenephrology modalities. However, the order of operations generally remains unchanged 
regardless of context. See Figure 2 for telenephrology service implementation order of 
operations. 
Budget 
 Budgeting for a new service involves various assumptions of costs, revenues, and 
outcomes. To appropriately inform these assumptions and subsequent cost-benefit analysis 
(CBA), thorough appraisal of historical budget data, new service cost, and budget projection 
timeline must occur. This project chose to incorporate a five-year budget timeline and pulled cost 
and revenue data from existing nephrology and telehealth budget data to reflect adoption of 
home dialysis telenephrology services. (CostHelper, 2021; Howard et al., 2015; Parkman, 2014; 
Penner, 2016; Salary.com, 2021; Srivatana, Liu, Levine & Kalloo, 2020; Trnka et al., 2015; 
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Zelman, McCue, Glick & Thomas, 2014). See Table 8 within Appendix E for a telenephrology 
services budget template. 
 Budgeting and CBA strategy will differ depending on whether clinics choose to offer 
telenephrology services in addition to standard in-person visits or adopt a service delivery that 
incorporate namely virtual visits and monitoring with minimal in-person encounters. 
Furthermore, consideration for frequency of remote-monitoring data assessment, dialysis 
prescription, and virtual visits with any member of the patient’s nephrology care team should be 
made to accurately project reimbursement. 
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Evaluation Plan 
 Considering the novelty of telenephrology services, comprehensive evaluation is critical 
to the success and sustainability of the program. Furthermore, reporting evaluation findings to 
inform and guide adoption outside of the institution is fundamental to stewarding access to these 
services. Using MAST as a guide for program evaluation, seven domains will be described to 
illustrate the necessary planning and deliverables. 
 Health problem and description of application. 
 To appropriate evaluate a telenephrology program, institutions will need to ground their 
evaluation in the findings of their needs assessment, goals, planning, and implementation 
procedures. Kidney disease in the context of an institution’s particular patient population should 
be thoroughly described. Additionally, description of the application of the telenephrology 
services, technical characteristics, and current use should be included. 
 Safety. 
 The evaluation should then investigate the safety of telenephrology services. This will 
include the safety of patients, staff, and reliability of devices. In the program planning phase, the 
coordination team should arrange for systems to report and store incidents for evaluation.  
 Clinical effectiveness. 
 To ensure telenephrology services are meeting or exceeding outcomes of standard care, 
aspects of patient health should be routinely evaluated. These would include effects on 
morbidity, mortality, health-related quality of life, behavioral outcomes, and usage of services. 
Ideally, this would also include rates of hospitalization, days of hospitalization, and number of 
ED visits.  
 Perceptions. 
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 Perceptions of patients, their support systems, and healthcare providers are important 
aspects of evaluating telenephrology services. Satisfaction, acceptance, understanding, 
confidence, ability, access, and self-efficacy should all be measured to inform how the program 
is perceived.  
 Economic aspects. 
 A societal and institution cost-benefit analysis of telenephrology services compared to 
standard care should be completed to identify areas in need of more efficient processes and to 
sustain institutional buy-in. There should be careful documentation of resource cost, resource 
amount, related changes in use of healthcare, and clinical effectiveness to analyze expenditures 
and revenues. Furthermore, economic evaluation will inform potential for scalability and 
expansion of services. 
 Organizational aspects. 
 From the planning phase through implementation and use of telenephrology services, 
documentation of resources that have been mobilized as well as resulting organizational changes 
should take place. In doing this, systems involved with telenephrology services can be evaluated 
to inform iterative assessment of processes and necessary corrections to workflow or staff roles. 
 Socio-cultural, ethical, and legal aspects. 
 Given the disparities that exist in patients with renal disease, assessment of 
telenephrology implications in vulnerable populations are essential to ensure equitable patient 
outcomes. This aspect of evaluation would include investigation of socio-cultural arenas of 
where the patient population dwells, ethical appraisal of service consequences, and required legal 
obligations.  
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Discussion 
While the pandemic brought on an unthinkable amount of hardship across the globe, 
diligent community collaboration allowed for innovation of solutions to maintain the safety and 
wellbeing of those most vulnerable in society. Amidst the devastation, there was a catalyst to 
achieve revolutionary strides in healthcare technology and practice advancement that will benefit 
generations to come. The achievements of healthcare progression are undoubtedly 
groundbreaking, but widespread adoption of novel services like telenephrology require thorough 
planning and evaluation to ensure their future efficacy in practice.  
Although telenephrology services are a relatively new and novel way of delivering 
healthcare, their benefit has been made evident in the literature. Studies have shown, 
implementation of telenephrology optimizes care to be more flexible, adaptable, and accessible. 
These benefits become exceedingly important in rural communities where mitigating for 
geographical barriers can have a positive impact on clinical outcomes. Beyond clinical outcomes, 
telenephrology services have been shown to improve patient quality of life and self-efficacy. 
Ultimately, the personal and societal impact of renal syndromes and their respective therapies 
can be ameliorated by removing the necessity to frequently travel to healthcare facilities and by 
facilitating self-monitoring and -management. When implemented appropriately, various 
modalities of telenephrology have proven to be a cost-benefit by reducing the number of missed 
appointments, airlift transportations, hospitalizations, and emergency room visits. 
Simultaneously, providers frequently benefit from improved workflow and reduced travel 
requirements to provide care.  
The literature used to inform this project produced limitations of the telenephrology 
program plan and evaluation. The novelty of virtual care delivery resulted in a dearth of large-
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scale and high-quality investigation of telenephrology interventions. Adoption of telenephrology 
programs in the U.S. have been relatively low when compared to countries with universal 
healthcare like Canada and Australia. This makes generalizing more abundant reports of 
international program cost-effectiveness findings to the United States’ private health insurance-
dominated system difficult. With the majority of U.S. telenephrology studies being conducted 
within the VA system, findings from these investigations are limited by non-diverse samples, 
being predominately male and white. Furthermore, the designs, intended use, and findings from 
telenephrology programs are exceedingly heterogenous creating challenges in holistic appraisal. 
Finally, telenephrology policy, reimbursement, barriers, and culture have changed dramatically 
because of the COVID-19 pandemic. The short timeframe between this catalyst event and the 
development of this project consequently led to a paucity of evidence for telenephrology 
programs that have been conducted within the pandemic phenomenon. Of the literature produced 
during the pandemic, very few have reported clinical outcomes and cost-effectiveness, 
presumably due to inadequate time for assessment of these aspects. While this program plan and 
evaluation had to rely on historical clinical outcomes data, mitigation for the aforementioned 
limitations was attempted by appraising current reimbursement policy for the budget and 
telehealth ethical implications for the program planning, implementation, and evaluation. 
Professional societies in nephrology have thwarted a call to action to consider 
implementation and reporting of telenephrology services in rural and underserved populations 
(Jain, Ahmad & Wallace, 2020; Koraishy & Rohatgi, 2020; Osman et al., 2017). Furthermore, 
the existing literature has expressed a resounding recommendation to evaluate and mitigate for 
disparities in telenephrology access (Agarwal, 2020; Batsis et al., 2019; Koraishy & Rohatgi, 
2020; Osman et al., 2017). This project was completed to satisfy the need for comprehensive 
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review of past implementation, evidence-informed program planning, and ethical evaluation of 
telenephrology delivery in rural settings of Western Washington State where caring for 
vulnerable patient populations is the norm. 
As there is a relative paucity of literature for telenephrology implementation and 
subsequent findings, institutions are strongly encouraged to report their processes, outcomes, and 
lessons learned to substantiate the need for evidence-based practice. Future studies would make 
meaningful contributions to the literature by planning to measure clinical outcomes, cost 
analyses, and ethical implications. 
Conclusions 
 The author created this project with the purpose of developing a telenephrology program 
plan and evaluation for rural settings in Western Washington State, informed by relevant 
epidemiology, pathophysiology, standards of care, and evidence in the literature. Lewin’s 
Change Theory was used as a theoretical framework for the telenephrology program proposal to 
illustrate driving and resisting forces to service delivery change. Appraisal of barriers to care for 
this patient population was reported and used to guide aspects of telenephrology program 
planning and evaluation with special consideration of access to devices, internet and cell 
coverage, technological literacy, and first language.  
Nephrology patients constitute a group of people who are characteristically burdened 
with comorbidities, high costs of care, impaired quality of life and invasive interventions. In 
rural settings of Western Washington, many patients are living with factors shown to impede 
access to quality, timely management of their disease resulting in a negative compounding effect 
on patient outcomes. This project provides evidence to support the adoption a new normal for 
nephrology care by incorporating telenephrology services and supplies guidance for planning, 
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implementation, and evaluation to assist healthcare providers and their institutions for successful 
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Appendix A 
Key Term Definitions 
 
Telenephrology: the application of telehealth or virtual care services to the management of 
 nephrology patients; a modality used between the patient and their nephrologists, 
 registered dietitians, certified diabetes educators, and other specialized members of a 
 nephrology care team. 
Telehealth: the use of electronic information and telecommunications technologies to support 
 long-distance clinical health care, patient and professional health-related education, 
 public health, and health administration. 
Virtual care: a broad term that encompasses all the ways healthcare providers remotely interact 
 with their patients. 
Nephrologist: an internist who treats disorders of the kidney, both chronic and acute, disorders of 
 high blood pressure, fluid, electrolyte and mineral balance, and manages complications of 
 kidney failure necessitating dialysis (removal of fluid and body wastes) when the kidneys 
 do not function. 
Certified Diabetes Educator: a health professional who specializes in educating, supporting, and 
 promoting self-management of diabetes. 
Registered Dietitian: food and nutrition experts who can translate the science of nutrition into 
 practical solutions for healthy living. 
Kidney Disease: impaired kidney function often characterized by nephrosis (severe loss of 
 plasma protein in the urine) and/or nephritic (inflammation often presenting with blood in 
 the urine) syndromes. 
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Chronic Kidney Disease: the gradual loss of kidney function evidenced by the syndromes of 
 kidney  disease. Symptoms usually do not become apparent until the kidney has become 
 significantly impaired. 
End Stage Renal Disease: the final and permanent stage of chronic kidney disease, where kidney 
 function has declined to the point that the kidneys can no longer function on their own. 
 Patients with end stage renal disease then rely on renal replacement therapies like dialysis 
 or kidney transplantation. 
Estimated Glomerular Filtration Rate: a calculated estimation of kidney function using a serum 
 creatinine blood test. The calculation factors in serum creatinine, age, body size and sex. 
 This rate is used to stage kidney disease and guides many therapeutic interventions. 
Renal Replacement Therapy: replaces nonendocrine kidney function in patients with acute or end 
 stage renal failure. Renal Replacement Therapy can include continuous hemofiltration 
 and hemodialysis, intermittent hemodialysis, and peritoneal dialysis. 
Diabetic Kidney Disease: a type of chronic kidney disease caused by diabetes. 
Renin Angiotensin System Inhibition: inhibition of a hormone system that regulates blood 
 pressure, fluid, and electrolyte balance through the use of drugs like angiotensin receptor 
 blockers and angiotensin converting enzyme inhibitors. 
Glycemic Control: management of blood glucose levels through diet, lifestyle, and medications. 
Hemoglobin A1c: a blood test to measure the average blood glucose over a three-month period. 
Albuminuria: albumin (a protein) found in the urine, indicating kidney disease. 
Serum Creatinine: a blood test used to calculate estimated glomerular filtration rate and assess 
 kidney function. 
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Appendix B 
Table Summarizing Kidney Disease Improving Global Outcomes Guidelines for Chronic 
Kidney Disease Management 
Table 1 
Summary of Kidney Disease Improving Global Outcomes Chronic Kidney Disease Management & 
Pharmacologic Guidelines  
Blood Pressure Control 
& RAS inhibition 
BP targets for both diabetic & non-diabetic adults with CKD 
o uAE < 30mg/24h → <140/<90 mmHg 
o uAE > 30mg/24h → <130/<80 mmHg 
Preference for ARB or ACEi antihypertensives 
o In all diabetic patients with CKD and uAE 30-300 mg/24h 
o In both diabetic & non-diabetic adults with CKD and uAE 
>300 mg/24h 
AKI Risk Consider all people with CKD at risk for AKI 
Dietary Protein, 
Sodium & advice 
All individuals with CKD 
o Receive expert dietary advice and information in the context 
of an education program, tailored to severity of CKD and 
the need to adjust sodium, phosphate, potassium, and 
protein intake where indicated 
For diabetic or non-diabetic adults with eGFR <30 mL/min 
o Reduce protein intake to 0.8 g/kg per day 
For adults with CKD 
o Avoid diet high in protein (>1.3 g/kg per day) 
o Lower dietary sodium intake to <2 g per day (5 g/day of 
NaCl) in adults, unless contraindicated 
Glycemic Control • Target HgbA1c of ~7% to prevent or delay progression of 
microvascular complications of diabetes 
• In patients at risk for hypoglycemia, avoid HgbA1c targets <7% 
• Raise HgbA1c target >7% in patients with comorbidities, limited 
life expectancy and risk for hypoglycemia 
Lifestyle For all adults with CKD 
o Undertake physical activity appropriate to cardiovascular 
health and tolerance 
o Achieve a healthy weight 
Note. ARB: angiotensin receptor blocker, ACEi: angiotensin converting enzyme inhibitor, AKI: acute 
kidney injury, RAS: renin-angiotensin system, uAE: 24-hour urine albumin excretion, HgbA1c: 
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Appendix D 
Tables 3 through 7 Summarizing the Evidence for Telenephrology Implementation by 
Intended Use 
Table 3 
Telenephrology Implementation for Screening and Primary Prevention 
Intervention Benefits Limitations 
Summary 
- Total of 6 studies 
- 3 studies using AI to 
screen or risk stratify 
- 4 studies using 
telenephrology as an 
early prevention tool 
- 1 study using 
telenephrology to 
prevent kidney stone 
recurrence 
- Can significantly improve 
identifying patients who are 
at risk for CKD 
- Presumably cost-effective 
compared to human-
powered screening 
- Means to achieve primary 
and secondary prevention 
- AI models may have more 
utility in patients who 
regularly access care 
- Newer studies do not yet 
have outcomes available to 
guide current practice 
- Some study samples make 
it difficult to generalize 
outcomes to other 
populations 
Song et al., 2020 
- AI analysis of EHR for 1-
year CKD diagnosis 
prediction 
- Dynamically updates with 
new events in patient 
timeline 
- Patients with diabetes 
- Based in U.S. 
- Out-performed validated 
models 
- Can significantly improve 
identifying patients who are 
at risk for CKD 
- Presumably cost-effective 
compared to human-
powered screening 
- Favors patients who follow 
up with provider as 
recommended → utility 
concern for patients with 
barriers to standard care 
Swee et al., 2020 
- Telenephrology 
dashboard for active 
surveillance of kidney 
disease 
- Use of EMR data for 
screening 
- Linked identified patients 
with virtual nephrology 
consult 
- VA branch patient panel 
- Based in U.S. 
- Identified 459 of 1284 
patients that were at risk for 
kidney disease 
- Identified patients were 
offered virtual consult with 
nephrologist 
- Patients saved between 
$21.60 and $63.90 per trip 
by using virtual consult 
- Number of steps to complete 
a consult request decreased 
from 13 to 9 
- Improved early detection 
and identification of disease 
- Improved access to care for 
rural populations 
- Number of days for 
completion of consultation 
did not change 
- 97.4% male sample 
- Measures for clinical 
outcomes forthcoming 
- Pilot program 
Sheng et al., 2020 
- Prognostic AI for 1st year 
mortality in patients using 
HD 
- Model performance 
testing 
- Based in China 
- Developed and validated 2 
machine learning models to 
predict 1st year mortality in 
patients undergoing HD 
- Relationships between data 
may change over time with 
advances in treatments and 
changes in the population 
- Training data was taken 
from a single dialysis center 
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- Helps identify high-risk 
patients beginning HD and 
allows for risk stratification 
- Sample from 97 different 
dialysis centers 
- Presumably cost-effective 
- Non-diverse sample; 
Chinese patients only 
- Only designed to predict 
1st year mortality 
Tuot et al., 2020 
- App to encourage 
behavior change, 
awareness, education, 
and enabling for patients 
at risk for and living with 
CKD 
- Pilot study through the VA 
- Based in U.S. 
- Used patient and clinician 
input to identify behavior 
changes suitable for 
intervention and barriers to 
behavior change 
- Provides patients a risk 
calculator that outputs 
information individualized to 
the patient’s calculated risk 
- Provides clinicians with a 
clinical practice toolkit that 
assist in discussing and 
managing patients’ risk for 
CKD 
- Aimed to prevent disease 
- Aimed to encourage self-
efficacy 
- Results forthcoming 
Gasparini et al., 2019 
- Kidney stone prevention 
organized by urologists 
and implemented by 
clinical pharmacists 
- Metabolic workup and 
dietary counseling via 
telephone 
- Northern California Kaiser 
Permanente 
- Feasibility pilot program 
- Based in U.S. 
- 99% of the 500 patients 
enrolled in the program 
reported compliance with 
dietary advice 
- 80% completed a metabolic 
workup within a year 
- Significant improvement in 
all urinary parameters in 
patients with calcium stones 
- Patients with major risk 
factors for renal tubular 
acidosis were referred to 
nephrology 
- Potentially cost-effective 
- Males>females 
Hao et al., 2017 
- Screening for 1-year 
relative risk for CKD with 
EHR data 
- Retrospective Cohort 
study 
- Evaluated model with 
health records of 95% of 
the population in the 
state of Maine 
- Based in U.S.  
- Stratifies patients into three 
levels of risk 
- Study showed the model was 
effective a risk classification 
- Can significantly improve 
identifying patients who are 
at risk for CKD 
- Presumably cost-effective 
compared to human-
powered screening 
- Patients with unidentified 
presence of CKD may have 
been included in the study 
- Did not factor in 
geographical, 
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Table 4 
Telenephrology Implementation for General Nephrology Care 
Intervention Benefits Limitations 
Summary 
- Total of 17 interventions 
- 8 interventions incorporated 
virtual visits 
- 7 interventions incorporated 
self-management 
- 8 interventions incorporated 
self-monitoring 
- 6 interventions incorporated 
educational information 
- 5 interventions had a focus 
on rural or remote 
populations 
- Improved access to care 
for patients in rural areas 
- Improved access to care 
for patients with 
transportation issues or 
who are frail or disabled 
- Efficient and accessible 
patient education 
- High patient and provider 
satisfaction 
- Improved surrogate 
measures 
- Clinical outcomes meet or 
exceed standard care 
- Cost-effective modalities 
of care 
- Lack of long-term 
outcomes data 
- Many study samples make 
it difficult to generalize 
outcomes to other 
populations 
- Many studies had small 
sample sizes 
- Limited physical exams 
- Unknown reliability of 
smartphone apps and 
some remote monitoring 
devices 
- Initial cost of equipment 
and infrastructure 
 
Donald et al., 2021 
- Web-based self-
management support for 
adults with CKD 
- (My Kidneys My Health) 
- Prototype co-design and 
usability testing 
- Patients with CKD (non-
dialysis and non-transplant) 
- Based in Canada 
- Usability scores were high 
(mean= 90/100) 
- Patient reported useful 
features including the 
personalized food tool, 
healthcare provider 
question list, symptom 
guidance based on CKD 
severity, and medication 
advice 
- Designed for patients and 
their caregivers/support 
system 
- Content is tailored to the 
patient 
- Used patient, caregiver, 
clinician, researcher, 
software developer, 
graphic designer and 
policy maker input to 
design the system and 
study 
- Patient-centered and 




- Small sample size; 18 
participants for focus 
groups and 5 participants 
for usability testing 
- Males>females 
- Urban participants>rural 
participants 
- All white participants 
- All participants had 
internet and electronic 
device access 
- Feasibility and larger study 
forthcoming 
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- Addresses barriers with in-
person visits and 
management 
Bowman et al., 2020 
- Mobile tablet-based 
educational tool to promote 
patient awareness of CKD 
safety; NSAIDS, 
hypoglycemia, AKI 
prevention, and contrast dye 
risk 
- Patients with any stage of 
CKD 
- Development and usability 
pilot study 
- Based in U.S. 
- 10 patients completed at 
least 90% of the modules 
- 7 participants rated the 
system as “very easy to 
use” 
- 10 participants said the 
activity length was 
appropriate and helpful 
- All participants said they 
would recommend the 
system to others 
- Incorporated patient 
feedback to enhance the 
system 
- Median rating of the 
system was 8 out of 10 (10 
being the best) 
- Small sample size; 12 
- All participants already 
owned a mobile phone 
and used it daily 
- Pilot study 
Chang et al., 2020 
- RD tele-counseling in rural 
settings 
- Smartphone app and phone 
calls 
- Based in U.S. 
 
- Participants reported high 
satisfaction with the 
intervention 
- Improved dietary sodium 
intake, weight, daytime 
blood pressure and 
healthy eating index (HEI)-
2015 scores 
- Addressed barriers of 
dietitian availability, travel 
distance, and cost 
- 8-week intervention 
- No clinical outcomes 
measured 
Diamantidis et al., 2018 & Kobe et al., 2020 
- Simultaneous risk factor 
control using telehealth to 
slow progression of DKD 
(STOP-DKD) 
- Multifactorial behavioral and 
medication management 
intervention to mitigate 
kidney function decline at 3 
years compared to usual 
care 
- Patients with DM, 
uncontrolled HTN, and 
evidence of kidney 
dysfunction 
- RCT 
- Among African American 
participants, the 
intervention arm had 
significantly greater 
preservation of eGFR 
- May be a beneficial 
intervention for African 
Americans 
- Patients from 7 primary 
care clinics 
 
- No difference in 
attenuation of kidney 
function decline of the 
sample as a whole 
- Non-African Americans 
paradoxically had worse 
outcomes (potentially type 
1 error or there may be a 
threshold for interventions 
becoming detrimental in 
populations that already 
have good access to care 
at baseline) 
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- Pharmacist telephone 
education modules, home 




electronically to PCPs 
- Based in U.S. 
Kyte et al., 2020 
- electronic Patient-Reported 
Outcome Measure (ePROM) 
system: remotely self-report 
- symptoms using a secure 
online platform and share 
data with the clinical team in 
real-time via the electronic 
patient record  
- patients with advanced CKD 
(pre-dialysis) 
- pilot trial 
- based in U.S. 
- Optimizes care 
- Potential to improve 
outcomes and reduce 
health service costs 
- incorporates longitudinal 
ePROM symptom data into 




- Results forthcoming 
Li et al., 2020 
- mHealth with social media to 
support self-management  
- patients with stage 1-4 CKD 
- prospective RCT 
- based in Taiwan 
- Intervention group had 
higher scores of self-
efficacy, self-management, 
QOL, steps per day, and 
eGFR 
- Decline of eGFR was 
significantly slower in the 
intervention group 






- 49 participants (25 
intervention group and 24 
in control group) 
- Patients were provided 
with a wearable device → 
concern for cost 
Ellis et al., 2019 
- Smart button mHealth 
system to self-track 
medication adherence and 
deliver feedback over text 
message 
- Patients with stages 1-4 CKD 
- Pilot study 
- Based in U.S. 
- Measured to be a feasible 
system to encourage 
medication adherence 
- Participants reported the 











- Small sample size; 5 
participants 
- 80% white sample 
- Males>females 
- 52-day study 
- Pilot study 
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Kelly et al., 2018 
- Text and phone diet 
coaching 
- Patients with stage 3-4 CKD 
vs standard care 
- RCT 
- Based in Australia 
- Measured to be feasible 
and acceptable 
- Facilitated self-monitoring 
and encouraged adoption 
of goal setting 
- Patients recruited from 3 
communities 
- Made ancillary services 
more accessible to rural 
populations 
- No clinical outcomes 
measured 
Tan et al., 2018; Rohatgi, Tan & Mehrotra, 2015 
- Telenephrology for remotely 
located patients 
- Telenephrology 
management vs in-person 
care 
- VA Renal CVT program 
- Retrospective review 
- Based in U.S. 




- Cancelled or no-show 
appointments had a 
significantly significant 
decrease (53.1% missed 
appointments prior to 
implementation and 28.5% 
missed appointments 
during intervention) in the 
telenephrology group 
- Frequency of attending 
appointments was greater 
in the telenephrology 
group than the in-person 
group 
- No change in composite 
end points (all-cause 
mortality, ESRD, or 
doubling of sCr) between 
groups 
- Improves access to rural or 
remote populations 
- Cost-effective 
- Underpowered in number 
and follow up time to 
detect small differences in 
renal outcomes 
- Males>females  
Warner et al., 2018 
- Telemonitoring blood 
pressure with Bluetooth 
device 
- Mean eGFR of sample; 36 
- Observational study 
- Based in U.K. 
- 52% participants provided 
>90% of the expected data 
and 72% provided >80% 
of the expected data.  
- The usability of the 




- Efficient data collection 
and storage 
- 25 participants 
- Study time of 90 days 
- Provided patients with the 
device → cost concerns 
- Improvements in blood 
pressure monitoring 
appeared to be short term 
- No measures for clinical 
outcomes 
- Males>females 
- Did not report race or 
ethnicity 
- Pilot study 
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Fink et al., 2016 
- Patient-reported safety 
events with interactive voice-
inquiry dial-response system 
(Safe Kidney Care study) 
- Patients went from using 
paper diary to digital diary 
- Patients with stage 3-5 CKD 
- 6-month analysis report 
- 54% of the 52 participants 
reported safety events with 
digital diary when only 
15% reported events in 
paper diary previously 
- Physician adjudicators 
found about half of the 
reports were clinically 
significant with about a 
quarter of them requiring 
action 
- Participants reported 
satisfaction with the digital 
diary and safety reporting 
- Encourages self-
monitoring 
- Presumably cost-effective 
- Data is limited by patient 
motivation to use the 
system 
- The self-reporting system 
elicited a response 
- No measure for clinical 
outcomes 
Ishani et al., 2016 
- Interprofessional team 
(nephrologist, nurse 
practitioner, nurses, clinical 
pharmacy specialist, 
psychologist, social worker, 
and dietitian) telehealth vs 
usual care 
- patients with moderate to 
advanced CKD  
- telehealth devices (touch 
screen computer and 
remote monitoring devices) 
- VA Renal CVT program 
- RCT 
- Based in U.S. 
- Feasible care delivery 
strategy in this population 
- No statistically significant 
worsening of primary 
composite end point (all-
cause mortality, 
hospitalization, ED visits, or 
nursing home admission 
- Large sample size; 451 
intervention participants 
and 150 control 
participants 
- Oversampled patients 
living in rural areas to 
provide improved access 
to care 
- No statistically significant 
evidence of superiority 
- Mostly white male 
participants; 97.3% white, 
98.5% male 
- Potentially underpowered 
- High cost associated with 
equipment and 
infrastructure (installing 
broadband into patients’ 
homes) 
Ladino et al., 2016 
- VA Telenephrology for 
patients residing in 
underserved areas 
- Retrospective and 
descriptive study 
- All stages of CKD 
- Based in U.S. 
- Statistically significant 
lowering of blood pressure 
- Renal function stabilized 
- Statistically significant 
improvement of potassium 
- Modality to overcome 
geographical barriers to 
care 
- Facilitated access to care 
for rural populations 
- Two-year study with 





- 95% of patients were male 
- No statistically significant 
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Ong et al., 2016 
- Smartphone based self-
management system 
integrated into nephrology 
care 
- Non-dialysis dependent 
patients with advanced CKD 
- Behavioral elements; blood 
pressure monitoring & 
medication management, 
symptom assessment, and 
tracking lab results 
- Providers received alerts 
when treatment thresholds 
were crossed or critical 
changes occurred  
- Based in U.S. 
- High user adherence 
- Statistically significant 
blood pressure reductions 
- 27% of masked 
hypertension cases 
identified 
- 127 medication 
discrepancies identified; 
59% of which could have 
caused harm 
- Patients reported feeling 
more confident and in 
control 
- Providers perceived 
patients were better 
informed and engaged 
- 6-month study 
- Not an RCT 
Blakeman et al., 2014 
- Telephone guided access to 
community support 
- RCT 
- Patients with stage 3 CKD 
- Health-related QOL 
significantly higher in 
intervention group 
- Significantly better 
proportion of blood 
pressure control in 
intervention group 
- Reported cost benefit in 
intervention group 
- Supports self-management 
- Provides support in cost 
effective way 
- 436 sample from 24 
general practices 
- 6-month study 
- No measure for clinical 
outcomes 
Diamantidis et al., 2013 
- Directed use of internet for 
health information (Safe 
Kidney Care study) 
- Patients with CKD 
- Prospective cohort study 
- Based in U.S. 
- Patients were able to 
access information about 
CKD safety concerns  
- 28.7% of the 108 Phase I 
participants visited the 
website during the one-
year observation period 
Diamantidis et al., 2012 
- Text, PDA, and website for 
medication safety 
- Non-dialysis dependent 
patients with CKD 
- Based in U.S. 
- Patients reported 
satisfaction with the 
resource 
- Findings are dated with 
advances in technology 
- Small sample; 20 
participants 
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Table 5 
Telenephrology Implementation for Dialysis Care 
Intervention Benefits Limitations 
Summary 
- A total of 16 interventions, 
14 of which were studies 
- 5 interventions had a focus 
for home dialysis 
- 5 interventions 
incorporated virtual visits 
- 7 interventions 
incorporated self-
management 
- 7 interventions 
incorporated self-
monitoring 
- 4 interventions 
incorporated patient 
education 
- 2 interventions had a focus 
for appointment adherence 
- 3 interventions had rural or 




- Better clinical outcomes 
- Improved QOL 
- Improved access for 
patients in rural or remote 
areas 
- Improved access for 
patients with transportation 
issues or who are frail or 
disabled 
- Improvement in clinical 
outcomes and surrogate 
measures 
- Encourage and support 
transplantation 
- Encourage and support 
home dialysis 
- Improve patient knowledge 
- Improve appointment and 
treatment adherence 
- Increased patient 
satisfaction 
- Many studies did not have 
measures for clinical 
outcomes 
- Many studies had small 
sample sizes 
- Many were pilot studies 
- Many study samples make 
it difficult to generalize 
outcomes to other 
populations  
- Many interventions require 
significant planning and 
infrastructure 
El Khoury et al., 2020 
- mHealth app (KELA.AE) for 
dietary assessment and 
self-monitoring 
- patients using HD 
- Pilot study 
- Based in United Arab 
Emirates 
- Protein and sodium intakes 
improved with use of the 
app 
- Serum iron improved with 
use of the app 
- Small sample; 23 
participants 
- No relevant change in 
serum phosphorus, 
potassium, and albumin 
levels 
- Short timeline; 2 weeks 
- Pilot study 
Kaiser et al., 2020 
- Virtual multidisciplinary 
care program for the 
management of ESRD 
(Cricket Health Program) 
- Mean baseline eGFR of 19 
- Matched Cohort study 
- Based in U.S. 
- Patients in the intervention 
cohort had significantly 
higher rates of starting a 
home dialysis treatment 
than in the control cohort 
- Patients who completed 
the program had 
significantly higher disease 
knowledge levels and were 
more likely to choose a 
home modality as their first 
dialysis choice 
- Majority white male 
participants 
- Observational study → 
concern for unmeasured 
confounders 
- Did not systematically 
assess transplant and 
conservative care 
- Pilot study 
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- High levels of patient 
satisfaction with the 
intervention 
- Incorporated a 
multidisciplinary team 
approach 
Dubin & Rubinsky, 2019 
- Online education program 
to improve patient 
knowledge and facilitate 
ESRD treatment option 
decision making 
- Patients with stage 4 & 5 
CKD 
- Pilot study through the VA 
- Based in U.S. 
- 8 out of the 25 participants 
could not make an ESRD 
treatment choice, all 
participants were able to 
make a choice after the 
intervention 
- Proportion of participants 
choosing transplant nearly 
doubled after the 
intervention 
- Choosing PD increased 
from 16% before the 
intervention to 52% after 
- Significant increase in 
knowledge and self-efficacy 
score 
- Provided support for 
difficult decision making 
- Facilitates timely planning 
- Presumably cost-effective 
- Small sample; 25 
participants 
- Pilot study 
- No measures for clinical 
outcomes 
- Predominately white and 
male sample 
Kiberd et al., 2018 
- eHealth portal 
(RelayHealth) for delivery of 
care to home dialysis 
patients 
- Single-arm pilot study 
- Patients receiving either 
home HD or PD 
- Based in Canada 
- Patients reported a positive 
experience with the service 
- Patients reported 
satisfaction with the 
eHealth portal 
- Median monthly phone 
consult time decreased 
after adoption of the portal 
- Small sample; 27 
participants 
- High rate of patient drop-
out 
- No clinical outcomes 
measured 
- Pilot study 
Malkina & Tuot, 2018 
- VA eHealth website 
- RRT education 
- Based in U.S. 
- High website traffic 
suggesting consumer 
demand 
- Increases health literacy 
- No study data available 
Ensell, 2017 
- In-patient dialysis 
telehealth 
- Solution to closing of 
dialysis unit at rural AZ 
hospital 
- Based in U.S. 
- Cost-effective; 
transportation cost savings 
of ~$2.7 million 
- Providing specialized care 
to patients living in 
resource isolation 




- No study data available 
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Hayashi et al., 2017 
- Smartphone platform 
(SMARTD) 
- Remote monitor & self-
manage between in-center 
HD sessions vs. standard 
HD care 
- RCT 
- Based in Japan 
- Improved QOL 
- Patients able to self-
monitor weight, serum 
potassium and serum 
phosphorus → these 
surrogate measures were 
comparable or better than 
control group 
- Participants reported app 
was user friendly 
- Small study size; 8 
intervention participants 
and 10 control participants 
- No clinical outcomes 
measured 
Liu et al., 2017 
- Remote monitoring 
systems for patients using 
HHD 
- Patients using 
chronic/long-term HHD 
- Pilot program 
- Field test of copresence 
perceptions 
- Based in Australia 
- Enhanced perception of 
health care professional 
copresence into the design 
to improve feelings of 
isolation 
- Overall this system 
improved patients’ feelings 
of being connected with 
their healthcare providers 
- Enhanced self-monitoring 
and self-management 
- High levels of satisfaction 
reported from patients, 
providers, and nurses 
- No comparison group 
- Only measured 
perceptions 
- Pilot study 
Krishna et al., 2016 
- Patients using PD in rural 
areas who transitioned 
from in-person to 
telehealth appointments 
- QOL surveys 
- Based in U.S. 
- Improved QOL 
- Reduced patient travel time 
(~2 hrs per appointment) 
- Improve illness 
intrusiveness ratings scale 
- No clinical outcomes 
measured 
Reddy & Aronoff, 2016 
- Remote monitoring 
(AutheniDate software) + 
standard HHD care vs. 
standard HHD care 
- Patients receiving HHD 
- Cohort (exposed vs. not 
exposed) 
- Based in U.S. 
- 44% less missed 
appointments with built in 
reminders 
- Patients were also able to 
receive education on the 
loaned android tablet 
- Allows for individualization 
of therapy 
- Encourages self-monitoring 
and self-management 
- No statistically significant 
change in percent of HD 
sessions missed 




- Patients requiring palliative 
care, in long-term care 
centers, with cognitive 
deficits and who lacked 
support were excluded 
from the sample 
- 4-month intervention 
- 7/17 participants had 75% 
or more adherence to self-
monitoring 
TELENEPHROLOGY  98 
- Barriers technology literacy 
impaired participant use of 
program 
Minatodoni & Berman, 2013; Berman et al., 2011 
- Remote monitoring + 
standard HHD care vs. 
standard HHD care 
- RCT 
- Based in U.S. 
- Improvement in number of 
hospitalizations, number of 
ED visits, number of 
hospital days if admitted 
- Risk for hospitalization, 
hospital days per study day, 
and Karnofsky score were 
comparable or better than 
control group 
- Cost effective; $91,000 
savings in hospital and ED 
charges 
- Extra support for HHD care 
- Encourages self-monitoring 
and self-management 
-  
Sicotte et al., 2011 
- Remote and satellite 
nephrology clinic access via 
videoconferencing 
- Patients receiving in-center 
HD 
- Cohort (pre & post) 
- Based in Canada 
 
- Improvement in number of 
medication changes 
- No statistically significant 
change in number of 
transfers to hospital, 
number of HD sessions, 
blood chemistry or Kt/V 
- Providing telenephrology 
to patients in remote areas 
- Small study size; 11 
participants 
Som et al., 2011 
- Text and voice messaging 
+ standard in-center HD 
care 
- Patients receiving in-center 
HD 
- RCT cross-over 
- Based in U.S. 
 
- Median appointment 
adherence increased 75% 
- Median number of 
unintended hospitalization 
days fell by 31% 
- 1:36 savings ratio from 
appointment adherence 
- Low risk intervention 
- Targeted to high-risk, low-
income and vulnerable 
patients 
- Determined visits were 
being missed because of 
feeling ill, lack of childcare 
resources and lack of 
transportation 
- Primarily non-white patients 
- No statistically significant 
change in number of days 
hospitalized or HD 
attendance 
- Small study size; 19 
participants 
- 12-week study 
Stark et al., 2011 
- Personal digital assistant 
dietary self-monitoring 
- Pilot studies for HD and PD 
- Based in U.S. 
- Patients using both HD and 
PD demonstrated excellent 
rates of self-monitoring 
- Pilot study 
- No measures for clinical 
outcomes 
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- Provides support for a 
complicated dietary 
regimen 
Whitten & Buis, 2008 
- Telemedicine for HD 
- Cohort (cross-sectional) 
- Dialysis centers 
- Based in U.S. 
- Providers and patients had 
positive perceptions of 
program 
- Clinical measures (Hgb, 
URR, albumin, Pi) met or 
exceeded 
recommendations made by 
Renal Network 11 
- Across three centers, 
conducted 747 clinical 
consultations 
- Included educational 
events 
- Despite success of program 
it was discontinued in 2007 
due to Medicaid and 
Medicare policies affirming 
dialysis centers were not 
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Table 6 
Telenephrology Implementation for Renal Transplant Care 
Intervention Benefits Limitations 
Summary 
- A total of 3 interventions 
- 2 interventions had a focus 
for medication adherence 
- 1 intervention had a focus 
for increasing access to 
transplantation in 
vulnerable populations 
- 1 intervention had a rural 
patient sample 
- All 3 interventions had a 
focus for self-management 
- Improved medication 
adherence 




- Promote access to 
transplantation in rural 
dwelling African Americans 
- Improved provider 
management of 
pharmacological therapies 
- No studies measured for 
clinical outcomes 
- Two out of three studies 
did not use rural 
populations in their sample 
- Some studies have samples 
that excluded vulnerable 
populations 
Cabacungan et al., 2018 
- Tablet-based education 
program on options for live 
donor kidney transplant 
- Translated the traditionally 
in-person TALK-SWI 
education program to 
virtual format with social 
worker counseling over 
phone call 
- African American patients 
with ESRD 
- Pilot program 
- Based in U.S. 
- 73% of participants 
preferred digital version of 
education 
- 80% of participants 
reported they would use 
the digital version over in-
person education 
- Cost-effective way to 
deliver information 
- Targeted to patients with 
the lowest rates of live 
donor kidney transplant  
- Focus on rural dwelling 
participants 
- Small sample size; 15 
participants 
- Most participants had 2+ 
years of college education, 
had internet access at 
home, and use the internet 
at least once a day → 
findings may not translate 
to different 
- Did not measure changes 
in rate of transplantation 
- Pilot study 
Reese et al., 2017 
- Automated reminders and 




- Wireless-enabled pill 
bottles with customized 
reminders and provider 
notification 
- RCT (1:1:1) 
- Patients in the group with 
wireless enabled pill bottle 
+ reminders + provider 
notifications had the 
highest rates of medication 
adherence  
- Assists patients and 
providers in avoiding 
unintentional medication 
non-adherence  
- Creates a social incentive 
for adherence 
- Intervention aimed at 
timeframe with highest risk 
for rejection (first 6 months) 
- Did not have clinical 
outcome measures 
- Patients from a single 
center 
- Exclusion criteria; poor 
English comprehension, 
and patients living 120+ 
miles from the center → 
concern with generalizing 
findings to relevant 
populations 
- Only measures pill bottle 
opening, not pill ingestion 
McGillicuddy et al., 2013 
- mHealth medication 
adherence and blood 
pressure control 
- Significant improvements in 
medication adherence and 
systolic blood pressures in 
intervention group 
- 3-month trial 
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- notifications sent to 
participants reminding 
them to take medication 
- renal transplant recipients 
- RCT 
- Physicians made more anti-
hypertensive medication 
adjustments in intervention 
group 
- Reported to be highly 
acceptable and useful to 
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Table 7 
Telenephrology Implementation for Provider-to-Provider 
Intervention Benefits Limitations 
Summary 
- A total of 4 interventions 
- 2 interventions were 
executed through the VA 
system 
- 1 intervention was strictly 
out-patient based 
- Efficient and timely 
nephrology consults 
- Improve access to specialty 
care in rural communities 
- Reduce complications 
- More cost-effective than 
building new facilities 
- PCP/generalist education 
and support 
- Require significant 
infrastructure to 
successfully implement 
- Very few studies measured 
for clinical outcomes 
Lea & Tannenbaum, 2020 
- Connecting generalist 
physicians in rural hospitals 
with nephrologists 
- Provided consults for 
dialysis, CKD, AKI, and 
electrolyte disturbances 
- Physical exams over 
videoconferencing and use 
of electronic stethoscopes 
- Based in U.S. 
- 78% complete or near 
complete renal recover 
after AKI 
- All patients had safe 
corrections of electrolyte 
disturbances within 24 hrs 
- Few HD complications 
were observed 
- Nephrologist satisfaction 
with quality of 
videoconference physical 
exam 
- Anecdotal evidence of 
hospitalist and nurse 
satisfaction 
- Improving access to 
nephrology care in rural 
hospitals in resource 
isolation 
- Review of services after two 
years of operation 
- Nephrologists cannot 
remotely examine urine 
sediment  
- Lack of multi-specialty 
expertise at institution 
resulting in less complex 
patients 
- Lack of buy-in from 
nephrologists not 
employed at the hospital 
- Lack of EMR congruency 
limited implementation 
Winocour et al., 2020; Hardy et al., 2019 
- ENHIDE (East and North 
Herts Institute of Diabetes 
and Endocrinology) 
diabetes renal telehealth 
- PCPs in rural areas 
- Focused to identify clinical 
needs of patients with 
diabetes and kidney 
disease 
- Pilot study 
- Based in U.S. 
- specialist appraisal of PCP 
patient panel identified 
significant unmet clinical 
needs 
- Improved coordination of 
care 
- Improved provider 
satisfaction 
- Increased access to 
specialized care for 
patients in rural 
communities 
- No measures for clinical 
outcomes 
- Pilot study 
Pichler et al., 2016; McAdams, Cannavo & Orlander, 2014 
- VA eConsults; PCP can ask 
nephrologist focused 
clinical questions 
- Saves travel time, reduces 
out-of-pocket expenses 
- No measures for clinical 
outcomes 
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- Descriptive survey 
- Based in U.S. 
(no-charge/co-pay clinic 
visits) 
- EMR makes eConsult and 
shared delivery of care 
feasible 
- Providers were satisfied 
with the program, 
endorsed improvement of 
knowledge, coordination of 
care, and felt consultation 
improved quality of care 
and job satisfaction  
- Reported to expedite 
diagnostic testing and 
treatment 
- Extends access to specialty 
care services 
- Directed adjustments to 
improve specialist 
satisfaction* → accounts for 
varying levels of complexity 
for 3 levels of RVUs 
- Lower specialist satisfaction 
early in implementation 
(workload valuation) → 
directed adjustments* 
- Not a suitable delivery for 
all consult requests 
Beste et al., 2016; Salgia et al., 2014 
- VA Specialty Care Access 
Network – Extension of 
Community Healthcare 
Outcomes (SCAN-ECHO) 
program with nephrology 
specialty 
- Participant (provider) 
survey 
- Based in U.S. with largest 
hub based out of Seattle 
serving the Pacific 
Northwest 
- Strong agreement with 
trainings’ impact 
on providers  
- strong agreement with 
trainings’ impact on care 
delivery  
- participation for more 
than one year was 
associated with greater 
perceived impact, 
particularly perceived 
patient access to specialty 
care 
- extends specialized 
nephrology mentorship to 
regions experiencing 
resource isolation 
- Clinical outcomes data 
reports were not found 
- Requires substantial 
infrastructure and planning 
- Providers serve a 
population that is mainly 
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Appendix E 
Table 8 Depicting a Budget Plan for Telenephrology Services 
 
Operating Budget Year 1 Year 2 Year 3 Year 4 Year 5 Total 
Telenephrology in Rural Healthcare Communities of Western Washington Costs  
Capital Expenditures for 
Telehealth 
Year 1 Year 2 Year 3 Year 4 Year 5 Total 
Telehealth devices (BP 
monitors/Medical supplies) 10,000 0 0 0 0 10000 
Hardware Packages  20,000 0 0 0 0 20000 
IT training  2,000 0 0 0 0 2000 
Capital Office Furniture 2500 0 0 0 0 2500 
Capital Telecommunications 1000 0 0 0 0 1000 
Sinking Fund (7%) 9000 0 0 0 0 9000 
Miscellaneous 1000 0 0 0 0 1000 
Total Capital Expenditures 45500 0 0 0 0 45500 
Capital Home Health Costs to 
the Patient  
Year 1 Year 2 Year 3 Year 4 Year 5 Total 
Equipment 7,500 0 0 0 0 7500 
Plumbing costs for at home  2,000 0 0 0 0 2000 
Total Home Capital 
Expenditures 
9,500 0 0 0 0 9500 
Recurring Non-salary Costs Year 1 Year 2 Year 3 Year 4 Year 5 Total 
Apps/Software/Web Services 1800 1800 1800 1800 1800 $9,000.00 
Telehealth Software (zoom)  2,400 2,400 2,400 2,400 2,400 $12,000.00 
Home Hemodialysis   -7,200 -7,200 -7,200 -7,200 -7,200 -$7,200.00 
Home Peritoneal Dialysis  -5,300 -5,300 -5,300 -5,300 -5,300 -$26,500.00 
Medications home dialysis  -114 -114 -114 -114 -114 -$570.00 
Business Insurance 6000 6000 6000 6000 6000 $30,000.00 
Cleaning Services 3600 3600 3600 3600 3600 $18,000.00 
Hazardous Waste Disposal 3600 3600 3600 3600 3600 $18,000.00 
Laboratory Tests 13200 13200 13200 13200 13200 $66,000.00 
Legal & Accounting Fees 3600 3600 3600 3600 3600 $18,000.00 
Malpractice Insurance ($4 million 
liability) 
7200 7200 7200 7200 7200 $36,000.00 
Marketing 3000 3000 3000 3000 3000 $15,000.00 
Medical Supplies 4000 4000 4000 4000 4000 $20,000.00 
Non-Capital Laboratory Supplies 2500 2500 2500 2500 2500 $12,500.00 
Non-Capital Medical Equipment 1500 1500 1500 1500 1500 $7,500.00 
Non-Capital Office Equipment 1250 1250 1250 1250 1250 $6,250.00 
Office Lease 48000 48000 48000 48000 48000 $240,000.00 
Office Supplies 6000 6000 6000 6000 6000 $30,000.00 
Professional Development 600 600 600 600 600 $3,000.00 
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Pharmaceuticals 4800 4800 4800 4800 4800 $24,000.00 
Printing/Postage/Shipping 600 600 600 600 600 $3,000.00 
Taxes & Licenses 300 300 300 300 300 $1,500.00 
Telephone/Answering 
Service/Paging Services 
5840 5840 5840 5840 5840 $29,200.00 
Travel & Professional Meetings 3000 3000 3000 3000 3000 $15,000.00 
Utilities 4800 4800 4800 4800 4800 $24,000.00 
Miscellaneous 0 0 0 0 0 $0.00 
Total Recurring Non-Salary 
Costs 
$114,976.00         $603,680.00 
Salary Costs Year 1 Year 2 Year 3 Year 4 Year 5 Total 
Nephrologists → (5.0 FTE's)  
(271,761 per salary) 
1358805 1358805 1358805 1358805 1358805 $6,794,025.00 
Receptionist → (3.0 FTE) (32,000) 96000 96000 96000 96000 96000 $480,000.00 
Nurses → (3.0 FTE) (87,000 per 
salary) 
261000 261000 261000 261000 261000 $1,305,000.00 
Medical Assistant → (3.0 FTE) 
(39,000 per salary) 
30000 30000 30000 30000 30000 $150,000.00 
Certified diabetes educators → 
(2.0 FTE) (87,000 per salary) 
261,000 261,000 261,000 261,000 261,000 $1,305,000.00 
Registered dietitians → (2.0 FTE) 
(68,000 per salary) 
136,000 136,000 136,000 136,000 136,000 $680,000.00 
Telenephrology Coordinator → 
(1.0 FTE) (66,000 per salary) 
66,000 66,000 66,000 66,000 66,000 $330,000.00 
Retirement Plan (7% matching) 2576 2576 2576 2576 2576 $12,880.00 
Health Insurance 9000 9000 9000 9000 9000 $45,000.00 
Miscellaneous 0 0 0 0 0 $0.00 
Total Salary Costs $2,220,381.00         $11,101,905.00 
TOTAL COSTS            x        
QUANTITATIVE BENEFITS Year 1 Year 2 Year 3 Year 4 Year 5 Total 
Revenues             
Patient Care Reimbursement 
($95/visit) 
864,500 546000 546000 546000 546000 $3,048,500.00 
Federal/State Grants 75000 75000 0 0 0 $150,000.00 
Total Revenues           $3,198,500.00 
Cost Avoidance Year 1 Year 2 Year 3 Year 4 Year 5 Total 
$ 9,900/Emergent Dialysis Cost  9,900 9,900 9,900 9,900 9,900 $49,500.00 
$31,837/travel compensation  31,837 31,837 31,837 31,837 31,837 $159,185.00 
Total Cost Avoidance           $208,685.00 
Total Benefits             
NET 
     
 x 
Cost/Benefit Ratio            x 
 
Common Procedural Technology (CPT) code; 90966 for usual monthly home dialysis assessment. 
Formulas are embedded in table to offer institutions an adaptable budget template. 
